|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22749977 |
|
NCBI chrNW_004936763:1,225,355...1,308,257
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
|
ISO |
mRNA, protein:increased expression:brain, neuron |
RGD |
PMID:16997484 |
RGD:2301088 |
NCBI chrNW_004936578:5,838,044...5,916,287
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
ISO |
mRNA:increased expression:hippocampal granule cell |
RGD |
PMID:19647005 |
RGD:2315956 |
NCBI chrNW_004936672:3,461,387...3,468,053
|
|
G |
Adcyap1r1 |
ADCYAP receptor type I |
|
ISO |
mRNA:decreased expression:dentate gyrus (rat) |
RGD |
PMID:19647005 |
RGD:2315956 |
NCBI chrNW_004936478:7,278,081...7,322,970
|
|
G |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
|
ISO |
|
RGD |
PMID:12225880 |
RGD:2314400 |
NCBI chrNW_004936659:2,794,520...2,822,795
|
|
G |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
|
ISO |
|
RGD |
PMID:12225880 |
RGD:2314400 |
NCBI chrNW_004936582:5,313,215...6,091,351
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
associated with Non-alcoholic Fatty Liver Disease; |
RGD |
PMID:18098300 |
RGD:5686804 |
NCBI chrNW_004936578:3,168,599...3,179,369
|
|
G |
Adm |
adrenomedullin |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:17263982 |
RGD:7364988 |
NCBI chrNW_004936528:8,005,223...8,007,586
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:17937935 PMID:27757725 |
RGD:4890367 |
NCBI chrNW_004936619:597,970...618,564
|
|
G |
Adora2b |
adenosine A2b receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27757725 |
|
NCBI chrNW_004936821:583,463...608,189
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
|
ISO |
|
RGD |
PMID:20451506 |
RGD:5129116 |
NCBI chrNW_004936486:4,400,467...4,401,588
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
|
RGD |
PMID:14630341 PMID:18336819 |
RGD:1598754 RGD:4145097 |
NCBI chrNW_004936504:5,985,407...5,987,453
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chrNW_004936484:19,713,299...19,721,144
|
|
G |
Agtr2 |
angiotensin II receptor type 2 |
|
ISO |
|
RGD |
PMID:22920387 |
RGD:6903870 |
NCBI chrNW_004936479:13,252,678...13,255,570
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
ISO |
protein:increased expression:Kupffer cell (rat) |
RGD |
PMID:16500929 |
RGD:2313040 |
NCBI chrNW_004936727:1,907,493...1,909,350
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
|
RGD |
PMID:21351045 |
RGD:5509067 |
NCBI chrNW_004936621:620,163...639,115
|
|
G |
Akt1s1 |
AKT1 substrate 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16397181 |
|
NCBI chrNW_004936664:3,657,170...3,664,375
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
|
RGD |
PMID:18635843 |
RGD:5509608 |
NCBI chrNW_004936677:3,232,183...3,241,307
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:cerebral hemisphere CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:14769366 PMID:15266012 PMID:19816089 |
RGD:1626152 RGD:2317531 |
NCBI chrNW_004936554:7,807,914...7,848,691
|
|
G |
Ang |
angiogenin |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:19666176 |
RGD:2325717 |
NCBI chrNW_004936880:39,372...40,070
|
|
G |
Angpt1 |
angiopoietin 1 |
|
ISO |
|
RGD |
PMID:19885826 |
RGD:2316041 |
NCBI chrNW_004936470:37,105,469...37,328,183
|
|
G |
Aoc3 |
amine oxidase copper containing 3 |
|
ISO |
|
RGD |
PMID:16339390 |
RGD:2313821 |
NCBI chrNW_004936490:17,549,836...17,564,867
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
ISO |
|
RGD |
PMID:18205898 |
RGD:2292105 |
NCBI chrNW_004936492:14,818,561...14,902,231
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
ISO |
protein:increased expression:placenta |
RGD |
PMID:18373555 |
RGD:2315671 |
NCBI chrNW_004936877:666,545...669,351
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO |
protein:increased expression:cerebral cortex mRNA, protein:increased expression:parietal cortex |
RGD |
PMID:19806476 PMID:20924629 PMID:20979759 PMID:21718723 |
RGD:5148016 RGD:5148022 RGD:5148037 RGD:5684013 |
NCBI chrNW_004936550:5,931,201...5,943,999
|
|
G |
Asl |
argininosuccinate lyase |
resistance |
ISO |
protein:increased expression:brain, neuron (rat) |
RGD |
PMID:17198704 |
RGD:1599263 |
NCBI chrNW_004936543:7,688,788...7,699,842
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
resistance |
ISO |
protein:increased expression:brain, neuron (rat) |
RGD |
PMID:17198704 |
RGD:1599263 |
NCBI chrNW_004936487:17,482,307...17,527,407
|
|
G |
Bad |
BCL2 associated agonist of cell death |
|
ISO |
protein:altered localization:brain, mitochondria |
RGD |
PMID:18347331 |
RGD:2292679 |
NCBI chrNW_004936599:4,924,349...4,933,683
|
|
G |
Bag1 |
BAG cochaperone 1 |
|
ISO |
|
RGD |
PMID:12215270 |
RGD:2296021 |
NCBI chrNW_004936524:1,793,001...1,804,145
|
|
G |
Bag3 |
BAG cochaperone 3 |
|
ISO |
protein:increased expression:hippocampus, astrocyte |
RGD |
PMID:12061864 |
RGD:2325848 |
NCBI chrNW_004936486:8,985,871...9,007,461
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:18083315 PMID:18221257 |
RGD:2290557 RGD:2293026 |
NCBI chrNW_004936664:2,968,103...2,973,652
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15449323 |
|
NCBI chrNW_004936497:2,209,136...2,373,580
|
|
G |
Bdnf |
brain derived neurotrophic factor |
|
ISO |
mRNA:increased expression:retina |
RGD |
PMID:20554625 |
RGD:4891135 |
NCBI chrNW_004936540:5,530,081...5,582,765
|
|
G |
Becn1 |
beclin 1 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:22306244 |
RGD:6483054 |
NCBI chrNW_004936490:17,518,100...17,531,126
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
ISO |
|
RGD |
PMID:19888517 |
RGD:2317562 |
NCBI chrNW_004936807:708,340...750,127
|
|
G |
Birc5 |
baculoviral IAP repeat containing 5 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:18053646 PMID:18159002 |
RGD:2293126 RGD:2293127 |
NCBI chrNW_004936594:2,812,165...2,820,618
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
|
ISO |
|
RGD |
PMID:11245809 |
RGD:2289024 |
NCBI chrNW_004936534:4,707,658...4,871,865
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
|
ISO |
mRNA:increased expression:dentate gyrus, granule cell |
RGD |
PMID:10996456 |
RGD:5129486 |
NCBI chrNW_004936726:1,543,263...1,711,422
|
|
G |
Bsg |
basigin (Ok blood group) |
|
ISO |
protein:increased expression:basal ganglia |
RGD |
PMID:16029217 |
RGD:2289063 |
NCBI chrNW_004936588:181,688...189,795
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:9712737 |
RGD:2289078 |
NCBI chrNW_004936567:1,310,525...1,314,469
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased expression:intestine |
RGD |
PMID:17981193 |
RGD:5129536 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
C3ar1 |
complement C3a receptor 1 |
|
ISO |
|
RGD |
PMID:15159277 |
RGD:5129702 |
NCBI chrNW_004936892:347,547...355,143
|
|
G |
C5ar1 |
complement C5a receptor 1 |
|
ISO |
|
RGD |
PMID:15158333 PMID:15159277 |
RGD:1600597 RGD:5129702 |
NCBI chrNW_004936664:1,026,216...1,033,438
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18490106 PMID:23875703 PMID:29568770 |
RGD:13792595 RGD:2293311 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Casp6 |
caspase 6 |
|
ISO |
protein:increased expression, increased activity:small intestine mucosa |
RGD |
PMID:15010362 |
RGD:2301320 |
NCBI chrNW_004936563:912,502...920,025
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chrNW_004936726:554,627...596,334
|
|
G |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:29568770 |
RGD:13792595 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
Cast |
calpastatin |
|
ISO |
|
RGD |
PMID:11035539 |
RGD:5509823 |
NCBI chrNW_004936523:6,688,153...6,798,184
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:8215636 PMID:16682413 PMID:19196076 PMID:20888583 PMID:23743330 PMID:23875703 |
RGD:5130200 RGD:5130760 |
NCBI chrNW_004936533:3,601,270...3,637,128
|
|
G |
Cav1 |
caveolin 1 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:17293479 |
RGD:2289123 |
NCBI chrNW_004936589:2,504,235...2,536,778
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
|
ISO |
mRNA:increased expression:aorta |
RGD |
PMID:9665468 |
RGD:4145482 |
NCBI chrNW_004936538:835,436...848,907
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:lung, secretion (mouse) protein:increased expression:gut |
RGD |
PMID:15542513 PMID:19558673 |
RGD:2307184 RGD:4891479 |
NCBI chrNW_004936490:253,279...259,947
|
|
G |
Ccnb1 |
cyclin B1 |
|
ISO |
protein;altered expression:cerebral cortex, hippocampus CA1, neuron |
RGD |
PMID:18278459 |
RGD:2315990 |
NCBI chrNW_004936480:400,287...407,677
|
|
G |
Ccne1 |
cyclin E1 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:17584601 |
RGD:2289275 |
NCBI chrNW_004936570:5,536,817...5,547,880
|
|
G |
Ccng1 |
cyclin G1 |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:9698156 |
RGD:2316027 |
NCBI chrNW_004936515:614,287...621,213
|
|
G |
Cd2ap |
CD2 associated protein |
|
ISO |
|
RGD |
PMID:16088078 |
RGD:1581187 |
NCBI chrNW_004936476:12,890,595...12,989,046
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936810:791,823...838,303
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:12388354 |
RGD:5508171 |
NCBI chrNW_004936514:6,936,915...6,947,246
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
|
RGD |
PMID:12388354 PMID:20659085 |
RGD:5490531 RGD:5508171 |
NCBI chrNW_004936513:10,607,617...10,620,403
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
|
ISO |
protein:increased expression:testis, macrophage protein:increased expression:kidney |
RGD |
PMID:16786159 PMID:16891795 |
RGD:2289354 RGD:2289369 |
NCBI chrNW_004936533:2,949,026...3,033,166
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
|
ISO |
|
RGD |
PMID:20403613 |
RGD:2326175 |
NCBI chrNW_004936557:5,344,373...5,364,234
|
|
G |
Cd59 |
CD59 molecule (CD59 blood group) |
|
ISO |
|
RGD |
PMID:10530491 |
RGD:1600493 |
NCBI chrNW_004936533:4,242,589...4,263,136
|
|
G |
Cdc42 |
cell division cycle 42 |
|
ISO |
protein:increased activation:hippocampus CA1 |
RGD |
PMID:17161586 |
RGD:2298583 |
NCBI chrNW_004936474:7,556,765...7,598,687
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10451498 PMID:16968891 |
RGD:10043817 |
NCBI chrNW_004936476:22,717,308...22,725,127
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
|
ISO |
protein:increased expression:skeletal muscle |
RGD |
PMID:15799773 |
RGD:2293627 |
NCBI chrNW_004936587:4,573,166...4,578,480
|
|
G |
Chat |
choline O-acetyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chrNW_004936728:653,654...702,433
|
|
G |
Cldn4 |
claudin 4 |
|
ISO |
protein:increased expression, altered localization:small intestine epithelium |
RGD |
PMID:17375208 |
RGD:2317600 |
NCBI chrNW_004936543:2,984,797...2,986,563
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
|
RGD |
PMID:19372445 |
RGD:2314674 |
NCBI chrNW_004936510:3,779,930...3,806,615
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
ISO |
|
RGD |
PMID:17565360 |
RGD:5686869 |
NCBI chrNW_004936471:34,438,676...34,475,005
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:19563789 |
RGD:4891956 |
NCBI chrNW_004936475:9,443,851...9,454,715
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion associated with Anemia, Sickle Cell;protein:increased expression:lung mRNA:increased expression:liver |
RGD |
PMID:16709871 PMID:18589091 PMID:19433855 |
RGD:2311376 RGD:5135307 RGD:5135441 |
NCBI chrNW_004936676:60,869...63,028
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
|
ISO |
protein:increased expression:retina |
RGD |
PMID:18709383 |
RGD:2306570 |
NCBI chrNW_004936617:4,224,131...4,239,080
|
|
G |
Cxcl8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12865660 |
|
NCBI chrNW_004936598:1,779,471...1,781,353
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
associated with Anemia, Sickle Cell;protein:increased expression:lung |
RGD |
PMID:19433855 |
RGD:5135307 |
NCBI chrNW_004936676:33,580...40,323
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:18589091 |
RGD:2311376 |
NCBI chrNW_004936762:66,636...69,694
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:18790177 |
RGD:4781446 |
NCBI chrNW_004936547:479,261...504,757
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:21664436 |
RGD:5144004 |
NCBI chrNW_004936565:1,917,970...1,919,027
|
|
G |
Dcc |
DCC netrin 1 receptor |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:17574219 |
RGD:2314372 |
NCBI chrNW_004936497:10,122,078...11,169,900
|
|
G |
Dsg1 |
desmoglein 1 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:19500802 |
RGD:2316254 |
NCBI chrNW_004936682:1,854,637...1,889,426
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17470888 PMID:18722366 |
RGD:4892577 |
NCBI chrNW_004936534:885,489...892,292
|
|
G |
Edn2 |
endothelin 2 |
|
ISO |
|
RGD |
PMID:1479622 |
RGD:1580920 |
NCBI chrNW_004936474:23,061,219...23,064,525
|
|
G |
Ednrb |
endothelin receptor type B |
|
ISO |
|
RGD |
PMID:18722366 |
RGD:4892577 |
NCBI chrNW_004936511:3,446,864...3,478,434
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
ISO |
protein:hypophosphorylation:cortex, hippocampus: |
RGD |
PMID:15211596 |
RGD:10401223 |
NCBI chrNW_004936588:2,259,236...2,267,692
|
|
G |
Efna5 |
ephrin A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936531:2,217,467...2,267,265
|
|
G |
Efnb2 |
ephrin B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936472:5,138,751...5,181,630
|
|
G |
Egf |
epidermal growth factor |
resistance |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16417467 PMID:16526316 |
RGD:6906916 |
NCBI chrNW_004936563:1,058,803...1,181,393
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
Lung Reperfusion Injury; protein:increased expression:lung, nucleus (rat) CTD Direct Evidence: marker/mechanism Lung Reperfusion Injury; protein:increased expression:lung, nucleus (mouse) |
RGD CTD |
PMID:12468449 PMID:16488723 PMID:16551742 PMID:19342415 |
RGD:5131887 RGD:5131903 RGD:5131904 |
NCBI chrNW_004936531:7,625,956...7,629,041
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19041636 |
|
NCBI chrNW_004936758:960,305...992,152
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
ISO |
protein:increased phosphorylation:kidney |
RGD |
PMID:15936177 |
RGD:1581062 |
NCBI chrNW_004936712:413,602...454,443
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
|
ISO |
protein:increased phosphorylation:kidney |
RGD |
PMID:15936177 |
RGD:1581062 |
NCBI chrNW_004936495:10,746,687...10,769,304
|
|
G |
Eno2 |
enolase 2 |
|
ISO |
|
RGD |
PMID:17683050 |
RGD:2293745 |
NCBI chrNW_004936709:904,647...913,445
|
|
G |
Ep300 |
E1A binding protein p300 |
treatment |
ISO |
retina retina; protein:altered localization:Hsp70, promoter (rat) |
RGD |
PMID:22143029 |
RGD:5686888 |
NCBI chrNW_004936492:696,982...778,132
|
|
G |
Epha2 |
EPH receptor A2 |
|
ISO |
|
RGD |
PMID:16735461 |
RGD:1580976 |
NCBI chrNW_004936474:3,648,395...3,673,856
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
|
RGD |
PMID:19471280 |
RGD:5688359 |
NCBI chrNW_004936675:350,357...392,919
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
ISO |
|
RGD |
PMID:19440222 |
RGD:2313668 |
NCBI chrNW_004936706:1,854,938...1,867,521
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936572:3,728,971...3,795,612
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
|
RGD |
PMID:20705928 |
RGD:5147777 |
NCBI chrNW_004936562:2,371,725...2,388,617
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
|
RGD |
PMID:29568770 |
RGD:13792595 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
|
ISO |
Rat model using human FGF1 |
RGD |
PMID:16635575 PMID:19497570 |
RGD:5509879 RGD:5509881 |
NCBI chrNW_004936504:11,590,687...11,684,410
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936662:1,886,176...1,928,998
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936471:11,636,733...11,692,782
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
protein:increased expression:brain CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:7922267 PMID:15121240 |
RGD:2293779 |
NCBI chrNW_004936488:4,384,710...4,388,118
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:15306117 |
RGD:1642465 |
NCBI chrNW_004936599:3,642,504...3,649,294
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:15121240 |
RGD:2293779 |
NCBI chrNW_004936493:4,308,683...4,327,102
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
ISO |
|
RGD |
PMID:17250641 |
RGD:2307361 |
NCBI chrNW_004936809:1,269,900...1,285,853
|
|
G |
Gast |
gastrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10594344 |
|
NCBI chrNW_004936490:16,636,146...16,636,548
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16581065 |
|
NCBI chrNW_004936602:3,037,862...3,044,863
|
|
G |
Gjb1 |
gap junction protein beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25530438 |
|
NCBI chrNW_004936762:389,655...398,035
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
|
ISO |
protein:decreased activity:brain |
RGD |
PMID:7808037 |
RGD:6484655 |
NCBI chrNW_004936601:5,415,857...5,435,964
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
|
ISO |
|
RGD |
PMID:11367746 |
RGD:13513922 |
NCBI chrNW_004936529:1,779,582...1,801,251
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
|
ISO |
|
RGD |
PMID:11367746 |
RGD:13513922 |
NCBI chrNW_004936704:1,031,476...1,075,662
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8215636 |
|
NCBI chrNW_004936470:7,765,810...7,770,837
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23743330 |
|
NCBI chrNW_004936529:997,943...999,123
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
|
ISO |
mRNA:decreased expression:hippocampus (rat) |
RGD |
PMID:20408958 |
RGD:4107069 |
NCBI chrNW_004936515:8,937,391...9,236,438
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
|
ISO |
|
RGD |
PMID:17639597 |
RGD:2316528 |
NCBI chrNW_004936651:2,756,559...3,401,806
|
|
G |
Grik5 |
glutamate ionotropic receptor kainate type subunit 5 |
|
ISO |
|
RGD |
PMID:17639597 |
RGD:2316528 |
NCBI chrNW_004936706:410,806...469,000
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat) |
RGD |
PMID:20350575 |
RGD:2325867 |
NCBI chrNW_004936530:8,286,101...8,612,183
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat) |
RGD |
PMID:20350575 |
RGD:2325867 |
NCBI chrNW_004936587:3,406,055...3,806,956
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:24904723 |
RGD:10401882 |
NCBI chrNW_004936792:531,076...579,083
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
|
RGD |
PMID:17142801 |
RGD:6903953 |
NCBI chrNW_004936599:2,197,681...2,200,642
|
|
G |
Hbegf |
heparin binding EGF like growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7635938 |
|
NCBI chrNW_004936531:9,332,939...9,345,039
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936734:354,798...428,356
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
ISO |
Limb Reperfusion Injury Spinal Cord Reperfusion Injury |
RGD |
PMID:16465055 PMID:23816242 |
RGD:9068924 RGD:9068927 |
NCBI chrNW_004936495:5,770,988...5,816,157
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
|
RGD |
PMID:22392147 |
RGD:10402071 |
NCBI chrNW_004936472:25,236,728...25,246,585
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:16009498 PMID:18398369 PMID:21724106 |
RGD:2315888 RGD:5508445 RGD:5508473 |
NCBI chrNW_004936549:1,378,536...1,400,501
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic protein:increased expression:serum, Bronchoalveolar Lavage Fluid |
RGD CTD |
PMID:12352873 PMID:12919086 PMID:16699460 PMID:16982915 PMID:17660127 PMID:17906103 PMID:19885035 PMID:23075401 PMID:25780291 |
RGD:1582708 RGD:4145338 RGD:4145514 |
NCBI chrNW_004936492:5,042,353...5,049,216
|
|
G |
Hrh3 |
histamine receptor H3 |
|
ISO |
|
RGD |
PMID:17169356 |
RGD:1626416 |
NCBI chrNW_004936514:9,862,104...9,865,614
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7922267 |
|
NCBI chrNW_004936727:1,732,323...1,735,128
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
|
ISO |
|
RGD |
PMID:10550516 PMID:10965299 |
RGD:7242748 RGD:7242749 |
NCBI chrNW_004936727:1,718,952...1,721,691
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
associated with Diabetes Mellitus, experimental (D003921): protein:increased expression:brain |
RGD |
PMID:22075494 |
RGD:5685650 |
NCBI chrNW_004936487:13,348,465...13,352,717
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10216529 |
|
NCBI chrNW_004936542:7,577,192...7,581,598
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19193722 |
|
NCBI chrNW_004936543:2,110,351...2,111,896
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11557319 PMID:23743330 |
|
NCBI chrNW_004936659:616,570...627,172
|
|
G |
Id3 |
inhibitor of DNA binding 3, HLH protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936474:8,758,098...8,759,684
|
|
G |
Ifng |
interferon gamma |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:19514843 |
RGD:2308950 |
NCBI chrNW_004936545:6,139,130...6,144,543
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
|
RGD |
PMID:16306169 |
RGD:1598442 |
NCBI chrNW_004936492:11,709,623...11,784,028
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12388354 PMID:16141682 PMID:18460982 PMID:19514843 |
RGD:1598625 RGD:2308950 RGD:5508171 |
NCBI chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il12a |
interleukin 12A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936519:6,166,060...6,180,652
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:18354382 |
RGD:2301685 |
NCBI chrNW_004936647:2,529,933...2,532,503
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:16052682 PMID:19394645 |
RGD:4889555 RGD:4889825 |
NCBI chrNW_004936612:2,306,963...2,325,086
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chrNW_004936783:1,210,715...1,218,315
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10594344 PMID:12468449 PMID:15829914 PMID:19058328 PMID:19673871 |
|
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Il6r |
interleukin 6 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chrNW_004936580:4,055,438...4,081,876
|
|
G |
Il6st |
interleukin 6 signal transducer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chrNW_004936480:11,867,573...11,913,563
|
|
G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chrNW_004936525:4,046,609...4,154,715
|
|
G |
Irak3 |
interleukin 1 receptor associated kinase 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chrNW_004936545:4,233,353...4,284,324
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
ISO |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chrNW_004936647:2,686,247...2,693,633
|
|
G |
Itga2b |
integrin subunit alpha 2b |
|
ISO |
|
RGD |
PMID:11705748 |
RGD:2316361 |
NCBI chrNW_004936541:813,815...828,826
|
|
G |
Itga5 |
integrin subunit alpha 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936512:11,588,818...11,612,580
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
ISO |
|
RGD |
PMID:11705748 |
RGD:2316361 |
NCBI chrNW_004936541:2,822,789...2,871,069
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
|
RGD |
PMID:20440769 |
RGD:6483026 |
NCBI chrNW_004936503:111,722...243,627
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7922267 |
|
NCBI chrNW_004936522:3,034,364...3,037,632
|
|
G |
Kcnj8 |
potassium inwardly rectifying channel subfamily J member 8 |
|
ISO |
|
RGD |
PMID:10708603 |
RGD:1581697 |
NCBI chrNW_004936548:5,125,583...5,132,490
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:hippocampus |
CTD RGD |
PMID:16526316 PMID:17402857 |
RGD:5684415 |
NCBI chrNW_004936482:17,537,697...17,581,320
|
|
G |
Keap1 |
kelch like ECH associated protein 1 |
|
ISO |
protein:decreased expression:brain, neuron, cytoplasm (mouse) protein:decreased expression:left coronary artery (rat) |
RGD |
PMID:18078953 PMID:21075092 |
RGD:6893270 RGD:6902919 |
NCBI chrNW_004936659:785,059...793,775
|
|
G |
Klk1 |
kallikrein 1 |
|
ISO |
|
RGD |
PMID:12746231 |
RGD:1641806 |
NCBI chrNW_004936889:534,127...537,913
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
ISO |
|
RGD |
PMID:17288738 |
RGD:2324630 |
NCBI chrNW_004936659:1,259,405...1,300,545
|
|
G |
Lep |
leptin |
|
ISO |
|
RGD |
PMID:21086559 |
RGD:5128549 |
NCBI chrNW_004936479:15,394,966...15,411,334
|
|
G |
Lig3 |
DNA ligase 3 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chrNW_004936538:206,179...228,487
|
|
G |
LOC101954950 |
aromatase |
|
ISO |
protein:increased expression:hippocampus (rat) |
RGD |
PMID:21114983 |
RGD:4890041 |
NCBI chrNW_004936471:13,107,603...13,136,910
|
|
G |
LOC101959685 |
complement C5 |
|
ISO |
|
RGD |
PMID:15158333 |
RGD:1600597 |
NCBI chrNW_004936487:9,391,774...9,474,168
|
|
G |
LOC101964209 |
C-C chemokine receptor type 1 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:20410256 |
RGD:5688141 |
NCBI chrNW_004936596:177,774...183,186
|
|
G |
LOC101966992 |
cytochrome b-245 heavy chain |
|
ISO |
Protein:increase expression:brain CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16766636 PMID:19193722 |
RGD:1599677 |
NCBI chrNW_004936502:4,631,750...4,676,686
|
|
G |
LOC101967032 |
cytochrome b-245 light chain |
|
ISO |
|
RGD |
PMID:15148062 |
RGD:1599683 |
NCBI chrNW_004936641:1,036,967...1,044,954
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
|
RGD |
PMID:20436217 |
RGD:2325213 |
NCBI chrNW_004936541:4,157,847...4,178,156
|
|
G |
LOC101969021 |
somatotropin |
treatment |
ISO |
|
RGD |
PMID:21439711 |
RGD:10003153 |
NCBI chrNW_004936541:4,524,397...4,528,234
|
|
G |
LOC101973029 |
cytochrome P450 2E1 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:21094789 |
RGD:4892235 |
NCBI chrNW_004936486:19,691,822...19,702,684
|
|
G |
Manf |
mesencephalic astrocyte derived neurotrophic factor |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:19773801 |
RGD:2325809 |
NCBI chrNW_004936529:2,774,651...2,777,960
|
|
G |
Map2 |
microtubule associated protein 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21948028 |
RGD:6483082 |
NCBI chrNW_004936845:475,406...752,600
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16699462 PMID:20302854 |
RGD:1582310 |
NCBI chrNW_004936728:1,775,746...1,893,895
|
|
G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
|
ISO |
protein:increased activity:hippocampus |
RGD |
PMID:16805806 |
RGD:2293339 |
NCBI chrNW_004936694:2,223,020...2,263,388
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19667931 PMID:20302854 |
|
NCBI chrNW_004936739:551,678...602,027
|
|
G |
Mb |
myoglobin |
|
ISO |
|
RGD |
PMID:12788661 |
RGD:1582427 |
NCBI chrNW_004936492:4,890,871...4,897,665
|
|
G |
Mc1r |
melanocortin 1 receptor |
no_association |
ISO |
|
RGD |
PMID:18757499 |
RGD:5687323 |
NCBI chrNW_004936641:193,885...198,730
|
|
G |
Mdk |
midkine |
|
ISO |
|
RGD |
PMID:15780085 |
RGD:1582475 |
NCBI chrNW_004936562:2,687,825...2,690,292
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:retina (rat) |
RGD |
PMID:17113948 |
RGD:2317505 |
NCBI chrNW_004936589:2,280,803...2,390,179
|
|
G |
Mif |
macrophage migration inhibitory factor |
disease_progression |
ISO |
|
RGD |
PMID:18055556 |
RGD:4891010 |
NCBI chrNW_004936619:1,207,058...1,208,010
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
associated with lung injury; mRNA, protein:increased expression:lung CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16251419 PMID:16551680 PMID:19545667 PMID:23075401 |
RGD:1582618 RGD:1582631 RGD:5129531 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased activity:lung |
CTD RGD |
PMID:8869312 PMID:10706834 PMID:12024109 PMID:16971220 PMID:19058328 PMID:20863214 PMID:21470877 |
RGD:5130958 |
NCBI chrNW_004936490:4,809,773...4,819,070
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
|
RGD |
PMID:19635467 |
RGD:6480529 |
NCBI chrNW_004936475:8,864,512...8,866,516
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
|
RGD |
PMID:23977093 |
RGD:7349380 |
NCBI chrNW_004936580:4,691,870...4,694,092
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25780291 |
|
NCBI chrNW_004936473:27,672,237...27,676,339
|
|
G |
Nes |
nestin |
|
ISO |
protein:increased expression:cerebral cortex |
RGD |
PMID:17569338 |
RGD:1642074 |
NCBI chrNW_004936580:5,837,949...5,847,499
|
|
G |
Nod2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
protein:increased expression:small intestine |
RGD |
PMID:20107953 |
RGD:5131440 |
NCBI chrNW_004936475:3,708,069...3,742,845
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
ISO |
|
RGD |
PMID:17451676 |
RGD:1642142 |
NCBI chrNW_004936558:5,162,471...5,302,488
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver protein:increased expression:venule, arteriole, endothelium (mouse) |
RGD CTD |
PMID:10383581 PMID:11592783 PMID:14599979 PMID:19673871 PMID:22019501 PMID:23061969 PMID:23075401 |
RGD:1580938 RGD:2325259 RGD:5509100 |
NCBI chrNW_004936538:4,052,277...4,097,051
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21968084 |
|
NCBI chrNW_004936527:6,427,147...6,445,770
|
|
G |
Nox4 |
NADPH oxidase 4 |
|
ISO |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:18438942 |
RGD:2324666 |
NCBI chrNW_004936736:230,465...394,859
|
|
G |
Oga |
O-GlcNAcase |
|
ISO |
|
RGD |
PMID:16899550 |
RGD:2305957 |
NCBI chrNW_004936600:3,983,983...3,996,360
|
|
G |
Oprm1 |
opioid receptor mu 1 |
|
ISO |
mRNA, protein:decreased expression:hippocampus |
RGD |
PMID:17360495 |
RGD:2316611 |
NCBI chrNW_004936489:6,506,207...6,567,136
|
|
G |
Otc |
ornithine transcarbamylase |
|
ISO |
protein:increased activity:serum |
RGD |
PMID:1499453 |
RGD:4144083 |
NCBI chrNW_004936502:5,234,253...5,291,891
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (rat) |
CTD RGD |
PMID:9390645 PMID:15696051 PMID:16798486 PMID:21850691 |
RGD:5510018 RGD:5510020 |
NCBI chrNW_004936526:3,102,468...3,147,601
|
|
G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
ISO |
|
RGD |
PMID:19142196 |
RGD:6483555 |
NCBI chrNW_004936485:2,611,313...2,866,260
|
|
G |
Pde5a |
phosphodiesterase 5A |
|
ISO |
|
RGD |
PMID:19474186 |
RGD:2314462 |
NCBI chrNW_004936869:24,265...117,120
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
protein:decreased expression:lung (rat) protein:increased expression:brain (mouse) |
RGD |
PMID:12121711 PMID:21872880 PMID:22382321 |
RGD:2311660 RGD:6766379 RGD:6771206 |
NCBI chrNW_004936541:4,873,459...4,919,787
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
ISO |
proetin:decreased dimerization:skeletal muscle (rat) |
RGD |
PMID:19100383 |
RGD:4108481 |
NCBI chrNW_004936480:1,188,408...1,273,210
|
|
G |
Pklr |
pyruvate kinase L/R |
|
ISO |
|
RGD |
PMID:17013507 |
RGD:1625588 |
NCBI chrNW_004936580:4,770,977...4,799,316
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12967936 |
|
NCBI chrNW_004936474:6,091,978...6,095,961
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
|
ISO |
protein:increased activity:alveolar macrophage |
RGD |
PMID:1642455 |
RGD:1642456 |
NCBI chrNW_004936481:3,559,377...3,689,797
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:9472885 PMID:15223382 |
RGD:2311674 |
NCBI chrNW_004936785:476,200...503,371
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
protein:increased expression:spinal cord (rat) CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:15181847 PMID:18586014 PMID:19663807 |
RGD:6483808 RGD:6483830 |
NCBI chrNW_004936521:5,238,128...5,243,829
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
|
ISO |
|
RGD |
PMID:18606671 |
RGD:6483829 |
NCBI chrNW_004936706:840,968...855,552
|
|
G |
Pld2 |
phospholipase D2 |
|
ISO |
mRNA:decreased expression:brainstem, cerebellum protein:increased expression:hippocampus CA1, hippocampus granule cell layer |
RGD |
PMID:17024567 PMID:17393174 |
RGD:2299901 RGD:2299902 |
NCBI chrNW_004936677:2,870,664...2,883,545
|
|
G |
Pnmt |
phenylethanolamine N-methyltransferase |
|
ISO |
protein:increased expression:medulla oblongata (human) |
RGD |
PMID:21061149 |
RGD:5128821 |
NCBI chrNW_004936490:14,858,682...14,861,614
|
|
G |
Polb |
DNA polymerase beta |
|
ISO |
protein:increased expression:cerebral cortex |
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chrNW_004936785:324,655...350,496
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: therapeutic liver ischemia/reperfusion injury |
CTD RGD |
PMID:19151258 PMID:21305343 |
RGD:5509942 |
NCBI chrNW_004936629:3,672,445...3,725,645
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12468449 PMID:24011919 PMID:24433871 |
|
NCBI chrNW_004936602:1,230,907...1,368,588
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
|
ISO |
|
RGD |
PMID:14762344 |
RGD:1580702 |
NCBI chrNW_004936520:1,987,989...2,146,473
|
|
G |
Ppp3cb |
protein phosphatase 3 catalytic subunit beta |
|
ISO |
|
RGD |
PMID:14615291 |
RGD:1580705 |
NCBI chrNW_004936521:5,576,705...5,614,738
|
|
G |
Prdx6 |
peroxiredoxin 6 |
|
ISO |
|
RGD |
PMID:16766642 |
RGD:1580710 |
NCBI chrNW_004936481:14,223,422...14,233,634
|
|
G |
Prkca |
protein kinase C alpha |
|
ISO |
|
RGD |
PMID:17905752 |
RGD:2292474 |
NCBI chrNW_004936541:6,231,604...6,488,201
|
|
G |
Ptafr |
platelet activating factor receptor |
treatment |
ISO |
|
RGD |
PMID:11139461 PMID:12812996 |
RGD:10043168 RGD:1581279 |
NCBI chrNW_004936474:12,333,905...12,337,140
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17239858 PMID:19038262 |
RGD:2292538 |
NCBI chrNW_004936735:1,252,414...1,338,318
|
|
G |
Ptges |
prostaglandin E synthase |
|
ISO |
|
RGD |
PMID:12431630 PMID:16864802 |
RGD:2300094 RGD:2300116 |
NCBI chrNW_004936487:16,959,263...16,968,909
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10594344 PMID:16385084 |
RGD:5688223 |
NCBI chrNW_004936487:10,745,465...10,758,812
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:decreased expression:kidney CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10588920 PMID:10594344 PMID:11567657 PMID:16247333 PMID:16386242 PMID:18258783 PMID:19673871 PMID:21394482 PMID:21944479 |
RGD:1580660 RGD:5135045 RGD:5508180 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
|
ISO |
protein:increased tyrosine phosphorylation:kidney |
RGD |
PMID:17620366 |
RGD:2292577 |
NCBI chrNW_004936470:10,379,855...10,578,531
|
|
G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
ISO |
protein:increased phosphorylation:hippocampus |
RGD |
PMID:15970382 |
RGD:1642621 |
NCBI chrNW_004936675:216,970...325,670
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:nucleus, liver |
CTD RGD |
PMID:18621400 PMID:20302854 PMID:23743330 |
RGD:2298777 |
NCBI chrNW_004936599:3,800,142...3,810,583
|
|
G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
ISO |
|
RGD |
PMID:16403835 |
RGD:1580913 |
NCBI chrNW_004936748:1,244,962...1,250,093
|
|
G |
Scfd1 |
sec1 family domain containing 1 |
|
ISO |
protein:increased expression:cerebral cortex |
RGD |
PMID:9195952 |
RGD:633771 |
NCBI chrNW_004936494:5,410,219...5,501,687
|
|
G |
Sele |
selectin E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17112405 PMID:19489247 PMID:23743330 |
RGD:2313598 |
NCBI chrNW_004936481:16,915,203...16,921,840
|
|
G |
Sell |
selectin L |
|
ISO |
|
RGD |
PMID:19489247 |
RGD:2313598 |
NCBI chrNW_004936481:17,022,421...17,032,105
|
|
G |
Selp |
selectin P |
|
ISO |
|
RGD |
PMID:18521901 PMID:21701413 |
RGD:2312314 RGD:6218990 |
NCBI chrNW_004936481:17,076,660...17,112,501
|
|
G |
Serpine2 |
serpin family E member 2 |
|
ISO |
|
RGD |
PMID:8261109 |
RGD:2317936 |
NCBI chrNW_004936569:5,642,328...5,668,278
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:23991040 |
RGD:8661644 |
NCBI chrNW_004936581:4,911,403...4,924,484
|
|
G |
Sftpc |
surfactant protein C |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:20560845 |
RGD:4144062 |
NCBI chrNW_004936555:5,966,610...5,982,083
|
|
G |
Si |
sucrase-isomaltase |
|
ISO |
|
RGD |
PMID:9724271 |
RGD:1625550 |
NCBI chrNW_004936707:1,153,538...1,228,220
|
|
G |
Sirt7 |
sirtuin 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28675767 |
|
NCBI chrNW_004936594:5,418,331...5,425,050
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:19781384 |
RGD:2313601 |
NCBI chrNW_004936474:24,205,878...24,236,611
|
|
G |
Slc30a4 |
solute carrier family 30 member 4 |
|
ISO |
mRNA:increased expression:brain |
RGD |
PMID:18289514 |
RGD:2299950 |
NCBI chrNW_004936471:8,125,839...8,155,720
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
ISO |
protein:decreased expression:renal proximal tubule |
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chrNW_004936597:1,667,700...1,684,533
|
|
G |
Slc6a11 |
solute carrier family 6 member 11 |
|
ISO |
|
RGD |
PMID:13678673 |
RGD:1299345 |
NCBI chrNW_004936602:2,437,653...2,564,309
|
|
G |
Slc8a1 |
solute carrier family 8 member A1 |
|
ISO |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chrNW_004936508:10,894,918...11,256,084
|
|
G |
Slc8a2 |
solute carrier family 8 member A2 |
|
ISO |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chrNW_004936664:1,116,543...1,139,586
|
|
G |
Slc8a3 |
solute carrier family 8 member A3 |
|
ISO |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chrNW_004936495:13,236,480...13,370,973
|
|
G |
Slc9a1 |
solute carrier family 9 member A1 |
|
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:19027022 PMID:20337040 |
RGD:6771332 |
NCBI chrNW_004936474:11,460,266...11,517,420
|
|
G |
Slco1b3 |
solute carrier organic anion transporter family member 1B3 |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:16858290 |
RGD:2303111 |
NCBI chrNW_004936548:5,593,908...5,682,187
|
|
G |
Slk |
STE20 like kinase |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:12965890 |
RGD:2304069 |
NCBI chrNW_004936600:2,134,374...2,193,302
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8215636 |
|
NCBI chrNW_004936514:7,618,382...7,620,790
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chrNW_004936530:9,312,965...9,315,593
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
ISO |
associated with Brain Ischemia;mRNA, protein:increased expression:cerebral cortex |
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chrNW_004936594:2,932,297...2,935,358
|
|
G |
Socs4 |
suppressor of cytokine signaling 4 |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chrNW_004936697:110,637...129,767
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
RGD CTD |
PMID:15364863 PMID:16397181 PMID:23061969 PMID:23743330 |
RGD:1580834 |
NCBI chrNW_004936500:10,345,154...10,352,873
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism|therapeutic |
RGD CTD |
PMID:8215636 PMID:15087276 PMID:15612529 PMID:16682413 PMID:19193722 PMID:19917352 PMID:21940958 PMID:23743330 |
RGD:1581259 RGD:1582141 |
NCBI chrNW_004936489:11,178,338...11,191,601
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
|
RGD |
PMID:20548025 |
RGD:6903275 |
NCBI chrNW_004936905:148,956...156,023
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
|
ISO |
protein:increased phosphorylation:hippocampus CA1 (rat) |
RGD |
PMID:20197063 |
RGD:2325012 |
NCBI chrNW_004936561:3,826,802...3,844,406
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
ISO |
protein:increased serine phosphorylation:brain protein:increased phosphorylation:kidney |
RGD |
PMID:15262323 PMID:17670769 |
RGD:1600103 RGD:2291900 |
NCBI chrNW_004936506:7,196,860...7,235,854
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chrNW_004936646:747,178...763,449
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chrNW_004936490:17,119,189...17,178,402
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chrNW_004936490:17,022,268...17,043,751
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chrNW_004936646:1,297,530...1,312,508
|
|
G |
Stc1 |
stanniocalcin 1 |
|
ISO |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:15485913 |
RGD:2324700 |
NCBI chrNW_004936555:7,240,649...7,251,668
|
|
G |
Stc2 |
stanniocalcin 2 |
|
ISO |
mRNA, protein:increased expression:cerebral cortex |
RGD |
PMID:15485913 |
RGD:2324700 |
NCBI chrNW_004936609:2,319,546...2,331,049
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
|
ISO |
associated with Cholestasis, Extrahepatic |
RGD |
PMID:8680115 PMID:15000260 |
RGD:1601451 RGD:1601475 |
NCBI chrNW_004936592:4,038,163...4,192,772
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16968891 |
|
NCBI chrNW_004936815:468,987...492,666
|
|
G |
Tfam |
transcription factor A, mitochondrial |
|
ISO |
|
RGD |
PMID:22266265 |
RGD:6767573 |
NCBI chrNW_004936614:4,595,973...4,605,040
|
|
G |
Tgfbr2 |
transforming growth factor beta receptor 2 |
|
ISO |
|
RGD |
PMID:15613744 |
RGD:1579926 |
NCBI chrNW_004936473:21,324,669...21,409,430
|
|
G |
Th |
tyrosine hydroxylase |
|
ISO |
protein:increased expression:medulla oblongata (human) |
RGD |
PMID:21061149 |
RGD:5128821 |
NCBI chrNW_004936794:478,651...486,887
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
|
RGD |
PMID:19342415 |
RGD:5131887 |
NCBI chrNW_004936620:2,563,900...2,568,117
|
|
G |
Thbs1 |
thrombospondin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936471:3,064,466...3,081,125
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chrNW_004936542:4,323,905...4,329,940
|
|
G |
Ticam1 |
toll like receptor adaptor molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25780291 |
|
NCBI chrNW_004936588:2,818,909...2,827,797
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
protein:decreased expression:brain |
RGD |
PMID:17551674 |
RGD:2290424 |
NCBI chrNW_004936492:6,996,627...7,046,137
|
|
G |
Tjp1 |
tight junction protein 1 |
|
ISO |
protein:decreased expression:brain, endothelial cell |
RGD |
PMID:19374856 PMID:19929946 |
RGD:2325127 RGD:2325135 |
NCBI chrNW_004936483:1,814,870...2,045,802
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:kidney |
CTD RGD |
PMID:15912106 PMID:25780291 |
RGD:2312727 |
NCBI chrNW_004936576:522,234...531,660
|
|
G |
Tlr3 |
toll like receptor 3 |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:21355876 |
RGD:5128693 |
NCBI chrNW_004936554:3,370,766...3,388,125
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver |
RGD CTD |
PMID:17126102 PMID:19473433 PMID:25780291 PMID:27064547 |
RGD:2312503 RGD:4144169 |
NCBI chrNW_004936487:6,519,140...6,532,018
|
|
G |
Tmbim6 |
transmembrane BAX inhibitor motif containing 6 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:18005084 |
RGD:2291961 |
NCBI chrNW_004936512:7,427,926...7,448,700
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10706834 PMID:12024109 PMID:15829914 PMID:16971220 PMID:17112405 PMID:18460982 PMID:19058328 PMID:23743330 PMID:23875703 PMID:24898700 |
|
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
|
RGD |
PMID:17109621 |
RGD:1624182 |
NCBI chrNW_004936709:1,407,327...1,421,448
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
protein:increased expression:brain, mitochondrion |
RGD |
PMID:17661174 |
RGD:2290568 |
NCBI chrNW_004936595:919,807...935,367
|
|
G |
Trpc6 |
transient receptor potential cation channel subfamily C member 6 |
treatment |
ISO |
|
RGD |
PMID:20554625 |
RGD:4891135 |
NCBI chrNW_004936551:6,173,588...6,282,971
|
|
G |
Trpm7 |
transient receptor potential cation channel subfamily M member 7 |
|
ISO |
mRNA,protein:increased expression:hippocampus |
RGD |
PMID:18395621 |
RGD:5684390 |
NCBI chrNW_004936471:12,564,617...12,666,229
|
|
G |
Txn |
thioredoxin |
|
ISO |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chrNW_004936559:2,811,786...2,822,528
|
|
G |
Txn2 |
thioredoxin 2 |
|
ISO |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chrNW_004936492:4,310,394...4,320,714
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
|
ISO |
mRNA:decreased expression:spinal cord mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 PMID:19409971 |
RGD:5685028 RGD:5685030 |
NCBI chrNW_004936492:10,185,096...10,244,466
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
|
ISO |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chrNW_004936619:3,789,940...3,847,286
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:18813897 |
RGD:2313108 |
NCBI chrNW_004936748:785,491...802,791
|
|
G |
Vegfc |
vascular endothelial growth factor C |
|
ISO |
|
RGD |
PMID:18704465 |
RGD:2315487 |
NCBI chrNW_004936516:7,217,543...7,332,531
|
|
G |
Vegfd |
vascular endothelial growth factor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chrNW_004936470:4,761,827...4,794,751
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chrNW_004936520:10,051,692...10,059,324
|
|
G |
Vip |
vasoactive intestinal peptide |
|
ISO |
|
RGD |
PMID:21693218 |
RGD:5685379 |
NCBI chrNW_004936489:5,425,778...5,434,483
|
|
G |
Wnt3a |
Wnt family member 3A |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23875703 |
|
NCBI chrNW_004936864:150,742...179,205
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12910483 PMID:23403765 |
RGD:7247700 |
NCBI chrNW_004936493:1,762,814...1,824,501
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chrNW_004936706:752,571...783,746
|
|
G |
Znf354a |
zinc finger protein 354A |
|
ISO |
mRNA:decreased expression:kidney |
RGD |
PMID:8382778 |
RGD:1300202 |
NCBI chrNW_004936647:16,233...18,411
|
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
|
RGD |
PMID:9916935 |
RGD:11341701 |
NCBI chrNW_004936537:4,637,028...4,647,915
|
|
G |
Pdgfd |
platelet derived growth factor D |
|
ISO |
|
RGD |
PMID:19213942 |
RGD:9854642 |
NCBI chrNW_004936551:3,974,140...4,197,852
|
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
treatment |
ISO |
|
RGD |
PMID:22217518 PMID:23769041 |
RGD:7245568 RGD:8695995 |
NCBI chrNW_004936727:1,418,342...1,422,005
|
|
G |
C3 |
complement C3 |
treatment |
ISO |
|
RGD |
PMID:25122638 |
RGD:11040803 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:22826618 |
RGD:11352297 |
NCBI chrNW_004936514:6,936,915...6,947,246
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
ISO |
liver |
RGD |
PMID:22826618 |
RGD:11352297 |
NCBI chrNW_004936513:10,607,617...10,620,403
|
|
G |
F7 |
coagulation factor VII |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:12095034 |
RGD:11049508 |
NCBI chrNW_004936472:505,751...515,375
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
|
RGD |
PMID:22217518 |
RGD:7245568 |
NCBI chrNW_004936472:25,236,728...25,246,585
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
treatment |
ISO |
|
RGD |
PMID:23985719 |
RGD:10041002 |
NCBI chrNW_004936474:158,376...282,310
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
|
RGD |
PMID:24598936 |
RGD:10450586 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
|
G |
Aco1 |
aconitase 1 |
|
ISO |
|
RGD |
PMID:20176611 |
RGD:11541086 |
NCBI chrNW_004936524:1,081,672...1,134,971
|
|
G |
Clu |
clusterin |
treatment |
ISO |
|
RGD |
PMID:22494435 |
RGD:9068431 |
NCBI chrNW_004936675:499,745...513,515
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
treatment |
ISO |
|
RGD |
PMID:18209025 |
RGD:9685339 |
NCBI chrNW_004936551:5,388,456...5,395,071
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
|
ISO |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chrNW_004936754:808,894...828,554
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
mRNA:increased expression:kidney: |
RGD |
PMID:11889420 PMID:15785371 |
RGD:10449491 RGD:11080974 |
NCBI chrNW_004936492:2,353,840...2,368,573
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
ISO |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chrNW_004936482:16,804,129...16,853,539
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
ISO |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chrNW_004936504:4,762,251...4,799,789
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
protein:increased secretion:T lymphocyte (human) |
RGD |
PMID:16387096 |
RGD:7241259 |
NCBI chrNW_004936521:5,238,128...5,243,829
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
protein:increased expression:kidney: |
RGD |
PMID:16221712 |
RGD:13208600 |
NCBI chrNW_004936602:1,230,907...1,368,588
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
protein:increased expression:kidney: |
RGD |
PMID:16221712 PMID:18192922 |
RGD:13208600 RGD:13208601 |
NCBI chrNW_004936543:1,032,543...1,040,956
|
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:22305384 |
RGD:10395369 |
NCBI chrNW_004936508:5,855,748...5,938,879
|
|
|
G |
Kit |
KIT proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA,protein:decreased expression:stomach: |
RGD |
PMID:20040059 |
RGD:12911222 |
NCBI chrNW_004936482:17,162,854...17,238,319
|
|
G |
Kitlg |
KIT ligand |
|
ISO |
mRNA:decreased expression:stomach: |
RGD |
PMID:20040059 |
RGD:12911222 |
NCBI chrNW_004936507:5,566,144...5,650,412
|
|
|
G |
Agt |
angiotensinogen |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:15001561 |
RGD:13515113 |
NCBI chrNW_004936484:19,713,299...19,721,144
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
treatment |
ISO |
|
RGD |
PMID:24232000 |
RGD:13792678 |
NCBI chrNW_004936588:612,255...614,894
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:23946597 |
RGD:13782356 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:23946597 |
RGD:13782356 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
protein:increased expression:heart, kidney, liver, lung |
RGD |
PMID:22493902 |
RGD:9685194 |
NCBI chrNW_004936531:9,572,392...9,575,771
|
|
G |
Cldn1 |
claudin 1 |
|
ISO |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chrNW_004936578:98,489...113,125
|
|
G |
Cldn3 |
claudin 3 |
|
ISO |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chrNW_004936543:2,952,054...2,953,313
|
|
G |
Cldn5 |
claudin 5 |
|
ISO |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chrNW_004936619:3,455,508...3,457,053
|
|
G |
Crp |
C-reactive protein |
|
ISO |
protein:increased expression:intestine: |
RGD |
PMID:17981193 |
RGD:5129536 |
NCBI chrNW_004936740:885,855...888,854
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
|
RGD |
PMID:9117128 |
RGD:11039476 |
NCBI chrNW_004936490:15,142,526...15,146,375
|
|
G |
F7 |
coagulation factor VII |
|
ISO |
human protein in a rat model |
RGD |
PMID:22920553 |
RGD:11041662 |
NCBI chrNW_004936472:505,751...515,375
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:29170412 |
RGD:13792603 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
|
RGD |
PMID:22093738 |
RGD:10402181 |
NCBI chrNW_004936472:25,236,728...25,246,585
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:19362701 |
RGD:10766423 |
NCBI chrNW_004936492:5,042,353...5,049,216
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:12095141 |
RGD:11522715 |
NCBI chrNW_004936659:616,570...627,172
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
|
RGD |
PMID:22777122 |
RGD:10403072 |
NCBI chrNW_004936503:111,722...243,627
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
ISO |
protein:increased expression:heart, kidney, liver, lung |
RGD |
PMID:22493902 |
RGD:9685194 |
NCBI chrNW_004936561:3,017,471...3,035,481
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
|
RGD |
PMID:15001561 |
RGD:13515113 |
NCBI chrNW_004936541:4,157,847...4,178,156
|
|
G |
LOC101976500 |
haptoglobin |
treatment |
ISO |
|
RGD |
PMID:11922743 |
RGD:11041790 |
NCBI chrNW_004936475:21,841,054...21,845,821
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
|
RGD |
PMID:16610051 |
RGD:7777112 |
NCBI chrNW_004936527:6,427,147...6,445,770
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:28382390 |
RGD:13440093 |
NCBI chrNW_004936475:19,771,384...19,785,034
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1 group H member 4 |
disease_progression |
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:23331901 |
RGD:15042883 |
NCBI chrNW_004936492:13,315,265...13,365,186
|
|
G |
Parg |
poly(ADP-ribose) glycohydrolase |
treatment |
ISO |
|
RGD |
PMID:15791006 |
RGD:13514040 |
NCBI chrNW_004936728:428,028...538,413
|
|
G |
Ppp1r15a |
protein phosphatase 1 regulatory subunit 15A |
|
ISO |
mRNA:increased expression:jejunum (human) |
RGD |
PMID:20965186 |
RGD:9999150 |
NCBI chrNW_004936664:2,910,609...2,914,205
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:15187522 |
RGD:11250409 |
NCBI chrNW_004936469:43,841,989...43,850,322
|
|
G |
Serpinc1 |
serpin family C member 1 |
treatment |
ISO |
|
RGD |
PMID:21046505 |
RGD:11035258 |
NCBI chrNW_004936481:13,981,014...13,993,750
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
protein:increased activity:plasma (rat) |
RGD |
PMID:12717359 |
RGD:11081012 |
NCBI chrNW_004936543:1,032,543...1,040,956
|
|
G |
Vwf |
von Willebrand factor |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:10365842 |
RGD:11080742 |
NCBI chrNW_004936709:1,578,137...1,741,877
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
ISO |
|
RGD |
PMID:23010742 |
RGD:13209016 |
NCBI chrNW_004936493:1,762,814...1,824,501
|
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
|
ISO |
mRNA:decreased expression:kidney |
RGD |
PMID:20528771 |
RGD:9685432 |
NCBI chrNW_004936470:4,964,526...5,011,808
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
treatment |
ISO |
|
RGD |
PMID:22015440 |
RGD:13703100 |
NCBI chrNW_004936532:5,864,851...5,904,005
|
|
G |
Adam2 |
ADAM metallopeptidase domain 2 |
|
ISO |
|
RGD |
PMID:11967014 |
RGD:10047130 |
NCBI chrNW_004936675:393,160...451,851
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
ISO |
|
RGD |
PMID:18272597 |
RGD:9684850 |
NCBI chrNW_004936640:959,405...967,305
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
ISO |
|
RGD |
PMID:21412771 |
RGD:8695946 |
NCBI chrNW_004936578:3,168,599...3,179,369
|
|
G |
Adm |
adrenomedullin |
treatment |
ISO |
protein:increased expression:serum: |
RGD |
PMID:20538296 |
RGD:7364948 |
NCBI chrNW_004936528:8,005,223...8,007,586
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
|
ISO |
|
RGD |
PMID:31089212 |
RGD:27226686 |
NCBI chrNW_004936474:26,680,736...26,696,996
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
|
RGD |
PMID:22022451 |
RGD:7241603 |
NCBI chrNW_004936558:4,362,693...4,387,705
|
|
G |
Anxa1 |
annexin A1 |
treatment |
ISO |
|
RGD |
PMID:20953576 |
RGD:7421585 |
NCBI chrNW_004936503:9,124,314...9,142,372
|
|
G |
Anxa5 |
annexin A5 |
|
ISO |
|
RGD |
PMID:21918686 |
RGD:7242028 |
NCBI chrNW_004936662:926,302...959,964
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
treatment |
ISO |
|
RGD |
PMID:26362957 |
RGD:13703110 |
NCBI chrNW_004936492:14,818,561...14,902,231
|
|
G |
Apoa1 |
apolipoprotein A1 |
treatment |
ISO |
|
RGD |
PMID:18535924 |
RGD:7241574 |
NCBI chrNW_004936542:2,111,055...2,112,626
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:22768306 |
RGD:10053607 |
NCBI chrNW_004936551:359,134...534,672
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chrNW_004936664:2,968,103...2,973,652
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:18221257 PMID:29285062 |
RGD:13792599 RGD:2293026 |
NCBI chrNW_004936497:2,209,136...2,373,580
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
|
ISO |
|
RGD |
PMID:18725957 |
RGD:7241559 |
NCBI chrNW_004936604:551,774...567,014
|
|
G |
Becn1 |
beclin 1 |
treatment |
ISO |
|
RGD |
PMID:26412257 |
RGD:11561958 |
NCBI chrNW_004936490:17,518,100...17,531,126
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:23698117 |
RGD:11561968 |
NCBI chrNW_004936486:18,449,371...18,460,435
|
|
G |
C3 |
complement C3 |
treatment |
ISO |
|
RGD |
PMID:19691975 |
RGD:7411689 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Casp7 |
caspase 7 |
|
ISO |
|
RGD |
PMID:17596683 |
RGD:5684536 |
NCBI chrNW_004936486:4,082,664...4,114,942
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
treatment |
ISO |
|
RGD |
PMID:22160777 |
RGD:7247742 |
NCBI chrNW_004936538:835,436...848,907
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:10966493 |
RGD:7204444 |
NCBI chrNW_004936531:9,572,392...9,575,771
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:25993320 |
RGD:11251055 |
NCBI chrNW_004936514:6,936,915...6,947,246
|
|
G |
Cfb |
complement factor B |
|
ISO |
|
RGD |
PMID:12538716 PMID:16467447 |
RGD:7242709 RGD:7242734 |
NCBI chrNW_004936727:1,595,872...1,602,274
|
|
G |
Ciita |
class II major histocompatibility complex transactivator |
|
ISO |
|
RGD |
PMID:14569092 |
RGD:7242896 |
NCBI chrNW_004936530:9,033,510...9,073,341
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:19196448 PMID:23143303 |
RGD:7257565 RGD:7257570 |
NCBI chrNW_004936704:1,372,137...1,393,355
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
|
RGD |
PMID:23143303 |
RGD:7257565 |
NCBI chrNW_004936504:4,898,947...4,927,195
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
|
ISO |
|
RGD |
PMID:9407517 PMID:22189844 |
RGD:7204675 RGD:7204727 |
NCBI chrNW_004936631:484,356...489,643
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:29073721 |
RGD:13825150 |
NCBI chrNW_004936469:39,794,613...39,798,448
|
|
G |
Daxx |
death domain associated protein |
|
ISO |
protein:increased expression:kidney: |
RGD |
PMID:18480747 |
RGD:9587836 |
NCBI chrNW_004936476:25,546,091...25,550,390
|
|
G |
Dhfr |
dihydrofolate reductase |
|
ISO |
mRNA,protein:decreased expression:kidney: |
RGD |
PMID:18408363 |
RGD:11040540 |
NCBI chrNW_004936469:67,962...83,116
|
|
G |
Drd3 |
dopamine receptor D3 |
treatment |
ISO |
|
RGD |
PMID:25989500 |
RGD:13506961 |
NCBI chrNW_004936536:1,580,732...1,616,726
|
|
G |
Egln1 |
egl-9 family hypoxia inducible factor 1 |
|
ISO |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chrNW_004936484:19,343,770...19,386,087
|
|
G |
Egln3 |
egl-9 family hypoxia inducible factor 3 |
|
ISO |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chrNW_004936494:8,240,272...8,267,487
|
|
G |
Eng |
endoglin |
|
ISO |
mRNA, protein:increased expression:kidney (rat) |
RGD |
PMID:16751653 |
RGD:7248779 |
NCBI chrNW_004936487:15,467,165...15,499,180
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
protein:altered localization:kidney (rat) |
RGD |
PMID:23936185 |
RGD:7257563 |
NCBI chrNW_004936492:696,982...778,132
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:19961832 PMID:25581532 |
RGD:10401077 RGD:11041698 |
NCBI chrNW_004936543:742,722...745,332
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:25883098 |
RGD:11341735 |
NCBI chrNW_004936537:4,637,028...4,647,915
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chrNW_004936576:1,322,406...1,329,743
|
|
G |
Fgb |
fibrinogen beta chain |
treatment |
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chrNW_004936576:1,306,076...1,313,485
|
|
G |
Fgg |
fibrinogen gamma chain |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chrNW_004936576:1,343,657...1,352,085
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
|
RGD |
PMID:11352844 |
RGD:7205629 |
NCBI chrNW_004936586:1,708,803...1,773,372
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
|
RGD |
PMID:19095962 |
RGD:7242184 |
NCBI chrNW_004936488:4,384,710...4,388,118
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
protein:increased expression:kidney: |
RGD |
PMID:20332418 |
RGD:9685723 |
NCBI chrNW_004936694:2,051,362...2,053,812
|
|
G |
Glo1 |
glyoxalase I |
|
ISO |
|
RGD |
PMID:19211689 |
RGD:7242566 |
NCBI chrNW_004936476:20,910,696...20,928,583
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
|
RGD |
PMID:24630969 |
RGD:10401866 |
NCBI chrNW_004936792:531,076...579,083
|
|
G |
Has1 |
hyaluronan synthase 1 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chrNW_004937026:125,622...132,141
|
|
G |
Has2 |
hyaluronan synthase 2 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chrNW_004936470:25,418,069...25,443,332
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
protein:increased expression:urine: |
RGD |
PMID:23019274 PMID:23085062 PMID:23552495 |
RGD:7244372 RGD:7245489 RGD:7245495 |
NCBI chrNW_004936515:6,030,402...6,051,161
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
severity treatment |
ISO |
|
RGD |
PMID:17519789 PMID:22432008 |
RGD:1626334 RGD:9068883 |
NCBI chrNW_004936495:5,770,988...5,816,157
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:21291499 |
RGD:10755580 |
NCBI chrNW_004936492:5,042,353...5,049,216
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
|
ISO |
protein:increased expression:kidney (rat) |
RGD |
PMID:23102208 |
RGD:10402775 |
NCBI chrNW_004936470:7,927,734...7,950,805
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
|
RGD |
PMID:7569112 |
RGD:7242788 |
NCBI chrNW_004936542:7,577,192...7,581,598
|
|
G |
Hyal1 |
hyaluronidase 1 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chrNW_004936529:1,838,212...1,842,399
|
|
G |
Hyal2 |
hyaluronidase 2 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chrNW_004936529:1,845,445...1,851,106
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
|
RGD |
PMID:28355607 |
RGD:14975115 |
NCBI chrNW_004936545:6,139,130...6,144,543
|
|
G |
Igf1r |
insulin like growth factor 1 receptor |
|
ISO |
mRNA: increased expression: kidney: 3 and 5 days post ischemia |
RGD |
PMID:10990448 |
RGD:7242905 |
NCBI chrNW_004936483:4,563,995...4,860,231
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
treatment |
ISO |
|
RGD |
PMID:19546526 |
RGD:7495779 |
NCBI chrNW_004936785:358,128...406,751
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:24079335 PMID:28664613 |
RGD:14975137 RGD:7364864 |
NCBI chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il18 |
interleukin 18 |
treatment |
ISO |
|
RGD |
PMID:22089199 |
RGD:8655971 |
NCBI chrNW_004936612:2,306,963...2,325,086
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
|
RGD |
PMID:20030532 |
RGD:7175501 |
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
rat model treated with human protein mouse model treated with human protein |
RGD |
PMID:9555664 PMID:16849996 PMID:18363573 |
RGD:6907101 RGD:6907359 RGD:6909149 |
NCBI chrNW_004936783:1,447,158...1,466,331
|
|
G |
Itgb2 |
integrin subunit beta 2 |
|
ISO |
Associated with renal transplant patients |
RGD |
PMID:11007822 PMID:20504838 |
RGD:6907049 RGD:6907073 |
NCBI chrNW_004936778:1,286,475...1,311,184
|
|
G |
Kcnj11 |
potassium inwardly rectifying channel subfamily J member 11 |
|
ISO |
protein:decreased expression:kidney |
RGD |
PMID:21250976 |
RGD:7297045 |
NCBI chrNW_004936528:1,685,015...1,688,220
|
|
G |
Kl |
klotho |
treatment |
ISO |
mRNA,protein:decreased expression:renal tubule: |
RGD |
PMID:16204278 |
RGD:10403064 |
NCBI chrNW_004936472:27,604,681...27,649,613
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
protein:increased expression:urine: |
RGD |
PMID:23085062 PMID:23364806 |
RGD:7245469 RGD:7245489 |
NCBI chrNW_004936487:15,721,752...15,725,396
|
|
G |
Lep |
leptin |
resistance |
ISO |
|
RGD |
PMID:22969992 |
RGD:6909133 |
NCBI chrNW_004936479:15,394,966...15,411,334
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:10980121 |
RGD:9685228 |
NCBI chrNW_004936697:20,861...38,568
|
|
G |
LOC101954950 |
aromatase |
treatment |
ISO |
|
RGD |
PMID:23552495 |
RGD:7244372 |
NCBI chrNW_004936471:13,107,603...13,136,910
|
|
G |
LOC101966907 |
histone H2AX |
treatment |
ISO |
|
RGD |
PMID:23726287 |
RGD:8693706 |
NCBI chrNW_004936542:4,046,930...4,049,017
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
|
RGD |
PMID:21680852 |
RGD:6893484 |
NCBI chrNW_004936541:4,157,847...4,178,156
|
|
G |
Map1lc3a |
microtubule associated protein 1 light chain 3 alpha |
treatment |
ISO |
|
RGD |
PMID:20075199 PMID:26412257 |
RGD:11561916 RGD:11561958 |
NCBI chrNW_004936561:6,104,748...6,106,348
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
treatment |
ISO |
|
RGD |
PMID:23952292 |
RGD:10412647 |
NCBI chrNW_004936560:3,988,696...4,197,953
|
|
G |
Mc1r |
melanocortin 1 receptor |
|
ISO |
protein:decreased expression:kidney outer medulla |
RGD |
PMID:18790174 |
RGD:5687322 |
NCBI chrNW_004936641:193,885...198,730
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
protein:increased activity:kidney |
RGD |
PMID:18055546 PMID:22950848 |
RGD:6909167 RGD:7174699 |
NCBI chrNW_004936490:4,809,773...4,819,070
|
|
G |
Muc1 |
mucin 1, cell surface associated |
treatment |
ISO |
|
RGD |
PMID:22019164 |
RGD:7245959 |
NCBI chrNW_004936580:4,691,870...4,694,092
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
mRNA:increased expression:kidney (rat) |
RGD |
PMID:17220792 |
RGD:7207777 |
NCBI chrNW_004936470:20,480,844...20,485,955
|
|
G |
Ndufb8 |
NADH:ubiquinone oxidoreductase subunit B8 |
|
ISO |
|
RGD |
PMID:22160772 PMID:24096033 |
RGD:13801197 RGD:13801199 |
NCBI chrNW_004936600:5,122,004...5,126,776
|
|
G |
Nes |
nestin |
|
ISO |
|
RGD |
PMID:24503548 |
RGD:11570523 |
NCBI chrNW_004936580:5,837,949...5,847,499
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
|
RGD |
PMID:29291552 |
RGD:13504682 |
NCBI chrNW_004936527:6,427,147...6,445,770
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
|
RGD |
PMID:20471588 |
RGD:7247717 |
NCBI chrNW_004936474:671,362...673,610
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:21545725 |
RGD:11035217 |
NCBI chrNW_004936475:19,771,384...19,785,034
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4 group A member 1 |
severity |
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:22343121 |
RGD:14700869 |
NCBI chrNW_004936512:9,486,096...9,508,338
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
|
RGD |
PMID:12531391 |
RGD:2317150 |
NCBI chrNW_004936602:3,411,106...3,418,826
|
|
G |
Pax2 |
paired box 2 |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:12444203 |
RGD:727468 |
NCBI chrNW_004936600:4,850,594...4,939,010
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
mRNA,protein:increased expression:tubule, S3 segment: |
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chrNW_004936492:2,353,840...2,368,573
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chrNW_004936482:16,804,129...16,853,539
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:10550325 PMID:12819032 |
RGD:1580850 RGD:8554477 |
NCBI chrNW_004936504:4,762,251...4,799,789
|
|
G |
Pkd2 |
polycystin 2, transient receptor potential cation channel |
|
ISO |
protein:increased expression:kidney (rat) |
RGD |
PMID:12454224 |
RGD:1580868 |
NCBI chrNW_004936905:76,781...128,995
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
treatment |
ISO |
|
RGD |
PMID:24918615 |
RGD:10059636 |
NCBI chrNW_004936477:4,881,230...5,488,208
|
|
G |
Rnls |
renalase, FAD dependent amine oxidase |
|
ISO |
|
RGD |
PMID:23393318 |
RGD:7327166 |
NCBI chrNW_004936735:659,826...1,048,135
|
|
G |
Serpinc1 |
serpin family C member 1 |
severity |
ISO |
|
RGD |
PMID:26108065 |
RGD:11354006 |
NCBI chrNW_004936481:13,981,014...13,993,750
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:24744439 |
RGD:12859042 |
NCBI chrNW_004936527:10,033,095...10,042,713
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
ISO |
|
RGD |
PMID:22324445 |
RGD:9495930 |
NCBI chrNW_004936521:10,296,097...10,316,673
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
|
ISO |
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chrNW_004936489:11,534,095...11,556,759
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
|
ISO |
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chrNW_004936489:11,605,403...11,627,786
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
ISO |
protein:decreased expression:renal proximal tubule, brush border membrane (rat) |
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chrNW_004936597:1,667,700...1,684,533
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
|
ISO |
|
RGD |
PMID:12819032 |
RGD:1580850 |
NCBI chrNW_004936561:3,826,802...3,844,406
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
severity |
ISO |
|
RGD |
PMID:12709397 |
RGD:7244143 |
NCBI chrNW_004936646:1,297,530...1,312,508
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
ISO |
|
RGD |
PMID:11796005 |
RGD:11062062 |
NCBI chrNW_004936506:10,103,120...10,172,800
|
|
G |
Tlr2 |
toll like receptor 2 |
treatment severity |
ISO |
|
RGD |
PMID:11801667 PMID:20130923 PMID:22750071 PMID:23023072 PMID:23239000 |
RGD:7207892 RGD:7207894 RGD:7207896 RGD:7240552 RGD:7241087 |
NCBI chrNW_004936576:522,234...531,660
|
|
G |
Tlr4 |
toll like receptor 4 |
treatment |
ISO |
|
RGD |
PMID:11801667 PMID:20130923 PMID:23239000 |
RGD:7207892 RGD:7240552 RGD:7241087 |
NCBI chrNW_004936487:6,519,140...6,532,018
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:19925291 |
RGD:2315112 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:22728466 |
RGD:7245543 |
NCBI chrNW_004936709:1,407,327...1,421,448
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:20164827 |
RGD:7240507 |
NCBI chrNW_004936748:785,491...802,791
|
|
G |
Vwf |
von Willebrand factor |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:12684225 |
RGD:11080744 |
NCBI chrNW_004936709:1,578,137...1,741,877
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
ISO |
associated with Diabetes Mellitus, Type 2 |
RGD |
PMID:20616412 PMID:22995295 |
RGD:7247637 RGD:7247695 |
NCBI chrNW_004936493:1,762,814...1,824,501
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
ISO |
|
RGD |
PMID:23762489 |
RGD:8695935 |
NCBI chrNW_004936578:3,168,599...3,179,369
|
|
G |
Adm |
adrenomedullin |
treatment |
ISO |
mRNA,protein:increased expression:liver,plasma: |
RGD |
PMID:19212187 |
RGD:7364958 |
NCBI chrNW_004936528:8,005,223...8,007,586
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:21431875 |
RGD:10402078 |
NCBI chrNW_004936727:1,418,342...1,422,005
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
treatment |
ISO |
protein:altered expression:liver (mouse) protein:altered expression:liver (rat) |
RGD |
PMID:29589772 PMID:30671488 |
RGD:14975297 RGD:15036807 |
NCBI chrNW_004936558:4,362,693...4,387,705
|
|
G |
Bad |
BCL2 associated agonist of cell death |
treatment |
ISO |
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22647552 PMID:22847887 |
RGD:10053673 RGD:10053710 |
NCBI chrNW_004936599:4,924,349...4,933,683
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
associated with Non-alcoholic Fatty Liver Disease mRNA:increased expression:liver |
RGD |
PMID:21092002 PMID:22647552 PMID:22847887 |
RGD:10053673 RGD:10053710 RGD:5134995 |
NCBI chrNW_004936664:2,968,103...2,973,652
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:21092002 PMID:22847887 |
RGD:10053710 RGD:5134995 |
NCBI chrNW_004936497:2,209,136...2,373,580
|
|
G |
Bcl2l1 |
BCL2 like 1 |
treatment |
ISO |
associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22847887 |
RGD:10053710 |
NCBI chrNW_004936485:18,654,046...18,707,324
|
|
G |
C3 |
complement C3 |
treatment |
ISO |
|
RGD |
PMID:19854450 |
RGD:11040888 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
Casp8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:15300206 PMID:23423194 |
RGD:14695087 RGD:8661760 |
NCBI chrNW_004936726:554,627...596,334
|
|
G |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:23364428 |
RGD:13782358 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
treatment severity |
ISO |
|
RGD |
PMID:28623253 |
RGD:14995305 |
NCBI chrNW_004936490:253,279...259,947
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:22564590 |
RGD:7183676 |
NCBI chrNW_004936531:9,572,392...9,575,771
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:14741776 |
RGD:8547795 |
NCBI chrNW_004936514:6,936,915...6,947,246
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
|
RGD |
PMID:18041715 |
RGD:27095942 |
NCBI chrNW_004936676:60,869...63,028
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:25769561 |
RGD:15090809 |
NCBI chrNW_004936543:742,722...745,332
|
|
G |
Epor |
erythropoietin receptor |
|
ISO |
protein:increased phosphorylation:liver: |
RGD |
PMID:25769561 |
RGD:15090809 |
NCBI chrNW_004936659:1,468,391...1,473,880
|
|
G |
F3 |
coagulation factor III, tissue factor |
treatment |
ISO |
|
RGD |
PMID:11750579 |
RGD:11341708 |
NCBI chrNW_004936537:4,637,028...4,647,915
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
ISO |
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chrNW_004936599:633,501...639,412
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
protein:increased expression:liver |
RGD |
PMID:16222447 PMID:17235585 PMID:18561025 |
RGD:14700680 RGD:1600351 RGD:2290283 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:18561025 |
RGD:14700680 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:23503399 |
RGD:9685021 |
NCBI chrNW_004936576:1,322,406...1,329,743
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
|
RGD |
PMID:12651615 |
RGD:7205470 |
NCBI chrNW_004936586:1,708,803...1,773,372
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
ISO |
associated with nonalcoholic fatty liver disease |
RGD |
PMID:28807209 |
RGD:13792730 |
NCBI chrNW_004936536:6,730,070...6,893,818
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
mRNA, protein:increased expression, altered localization:serum, hepatocyte, cytoplasm protein:increased oxidation:liver |
RGD |
PMID:21431875 PMID:22514737 PMID:24578610 |
RGD:10402068 RGD:10402078 RGD:10402175 |
NCBI chrNW_004936472:25,236,728...25,246,585
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:20446775 |
RGD:10755725 |
NCBI chrNW_004936492:5,042,353...5,049,216
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
associated with Intestinal Reperfusion Injury;protein:increased expression:liver |
RGD |
PMID:7884306 PMID:8780571 |
RGD:11520784 RGD:14402044 |
NCBI chrNW_004936659:616,570...627,172
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
|
RGD |
PMID:28938192 |
RGD:14985248 |
NCBI chrNW_004936483:15,845,777...15,864,341
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
treatment |
ISO |
|
RGD |
PMID:22381173 |
RGD:12791280 |
NCBI chrNW_004936809:1,280,254...1,306,964
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:21911118 |
RGD:7364839 |
NCBI chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il18 |
interleukin 18 |
treatment |
ISO |
|
RGD |
PMID:14999688 PMID:25919765 |
RGD:14696667 RGD:14696668 |
NCBI chrNW_004936612:2,306,963...2,325,086
|
|
G |
Il18bp |
interleukin 18 binding protein |
|
ISO |
mRNA,protein:increased expression:liver |
RGD |
PMID:25919765 |
RGD:14696667 |
NCBI chrNW_004936498:1,353,569...1,358,312
|
|
G |
Il1a |
interleukin 1 alpha |
treatment |
ISO |
mRNA:increased expression:lung protein:increased expression:serum |
RGD |
PMID:9840148 PMID:19283466 PMID:19595018 |
RGD:11059517 RGD:2314952 RGD:6907377 |
NCBI chrNW_004936783:1,210,715...1,218,315
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
associated with Cholestasis |
RGD |
PMID:21468628 |
RGD:7175318 |
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO |
rat model treated with human protein |
RGD |
PMID:9000676 PMID:12451245 |
RGD:6909138 RGD:8551710 |
NCBI chrNW_004936783:1,447,158...1,466,331
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
ISO |
|
RGD |
PMID:22288937 |
RGD:10403073 |
NCBI chrNW_004936503:111,722...243,627
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:12134092 |
RGD:9685192 |
NCBI chrNW_004936561:3,017,471...3,035,481
|
|
G |
LOC101966907 |
histone H2AX |
treatment |
ISO |
|
RGD |
PMID:23792534 |
RGD:8693718 |
NCBI chrNW_004936542:4,046,930...4,049,017
|
|
G |
LOC101969148 |
cytochrome P450 1A1 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chrNW_004936471:33,682,730...33,688,332
|
|
G |
LOC101976500 |
haptoglobin |
treatment |
ISO |
|
RGD |
PMID:17187421 PMID:21699906 |
RGD:11041815 RGD:1626366 |
NCBI chrNW_004936475:21,841,054...21,845,821
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
protein:increased activity:liver: |
RGD |
PMID:11679968 |
RGD:10412680 |
NCBI chrNW_004936728:1,775,746...1,893,895
|
|
G |
Mfn2 |
mitofusin 2 |
treatment |
ISO |
mRNA, protein:decreased expression:liver (rat) |
RGD |
PMID:24898700 PMID:27363631 |
RGD:12910833 RGD:13204829 |
NCBI chrNW_004936474:767,754...795,258
|
|
G |
Mmp15 |
matrix metallopeptidase 15 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chrNW_004936475:9,951,876...9,971,631
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
ISO |
associated with Fatty Liver;mRNA, protein:decreased expression, decreased activity:liver |
RGD |
PMID:17255325 |
RGD:8547976 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
mRNA, protein:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chrNW_004936580:4,691,870...4,694,092
|
|
G |
Muc4 |
mucin 4, cell surface associated |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chrNW_004936784:515,608...539,915
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2 like 2 |
treatment |
ISO |
|
RGD |
PMID:22288937 PMID:31952110 |
RGD:10403073 RGD:21201304 |
NCBI chrNW_004936509:6,589,967...6,621,171
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
|
RGD |
PMID:28966130 |
RGD:13450941 |
NCBI chrNW_004936527:6,427,147...6,445,770
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:12605111 PMID:18507760 |
RGD:11100021 RGD:11100046 |
NCBI chrNW_004936469:43,841,989...43,850,322
|
|
G |
Serpinc1 |
serpin family C member 1 |
treatment |
ISO |
|
RGD |
PMID:8589354 PMID:24726586 |
RGD:10450597 RGD:11038771 |
NCBI chrNW_004936481:13,981,014...13,993,750
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
protein:increased activity:plasma (rat) |
RGD |
PMID:12353078 |
RGD:8547901 |
NCBI chrNW_004936543:1,032,543...1,040,956
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:16367929 |
RGD:1580273 |
NCBI chrNW_004936581:4,911,403...4,924,484
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
ISO |
|
RGD |
PMID:24557422 |
RGD:9497542 |
NCBI chrNW_004936521:10,296,097...10,316,673
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
|
ISO |
|
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chrNW_004936514:7,618,382...7,620,790
|
|
G |
Sod1 |
superoxide dismutase 1 |
treatment |
ISO |
human gene in a rat model |
RGD |
PMID:11779401 PMID:16555330 |
RGD:1581095 RGD:8655889 |
NCBI chrNW_004936500:10,345,154...10,352,873
|
|
G |
Tert |
telomerase reverse transcriptase |
treatment |
ISO |
|
RGD |
PMID:19545665 |
RGD:11038676 |
NCBI chrNW_004936815:468,987...492,666
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
ISO |
|
RGD |
PMID:9921794 |
RGD:11062061 |
NCBI chrNW_004936506:10,103,120...10,172,800
|
|
G |
Tlr2 |
toll like receptor 2 |
treatment |
ISO |
|
RGD |
PMID:16038046 PMID:25769561 |
RGD:15090805 RGD:15090809 |
NCBI chrNW_004936576:522,234...531,660
|
|
G |
Tlr4 |
toll like receptor 4 |
treatment severity |
ISO |
protein:increased expression:membrane raft: mRNA:increased expression:liver |
RGD |
PMID:21431875 PMID:21693218 PMID:22797797 PMID:23395256 PMID:27064547 |
RGD:10402078 RGD:14697698 RGD:14697699 RGD:14697702 RGD:5685379 |
NCBI chrNW_004936487:6,519,140...6,532,018
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
protein:increased expression:serum (rat) |
RGD |
PMID:10454827 PMID:11129814 PMID:11592783 PMID:15457564 PMID:17164725 PMID:19357028 PMID:21125813 PMID:24726586 |
RGD:10450597 RGD:14696803 RGD:14985257 RGD:14985258 RGD:14995447 RGD:14995473 RGD:15039406 RGD:2325259 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased localization:mitochondrion |
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chrNW_004936709:1,407,327...1,421,448
|
|
G |
Tradd |
TNFRSF1A associated via death domain |
treatment |
ISO |
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chrNW_004936475:17,628,297...17,634,919
|
|
G |
Ucp2 |
uncoupling protein 2 |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:22195248 |
RGD:7175309 |
NCBI chrNW_004936498:3,059,700...3,066,112
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
|
RGD |
PMID:26451003 |
RGD:15036791 |
NCBI chrNW_004936476:16,245,134...16,261,180
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
ISO |
|
RGD |
PMID:24768926 |
RGD:13209011 |
NCBI chrNW_004936493:1,762,814...1,824,501
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chrNW_004936664:2,968,103...2,973,652
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chrNW_004936497:2,209,136...2,373,580
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Egr1 |
early growth response 1 |
treatment |
ISO |
|
RGD |
PMID:22878149 PMID:23232597 |
RGD:10395282 RGD:10395299 |
NCBI chrNW_004936531:7,625,956...7,629,041
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:22115333 |
RGD:10402095 |
NCBI chrNW_004936472:25,236,728...25,246,585
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:21227458 |
RGD:10755577 |
NCBI chrNW_004936492:5,042,353...5,049,216
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:22503847 |
RGD:7240537 |
NCBI chrNW_004936659:616,570...627,172
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
protein:increased expression:lung (rat) |
RGD |
PMID:23122581 PMID:23142117 |
RGD:7183185 RGD:7204125 |
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Il4 |
interleukin 4 |
treatment |
ISO |
|
RGD |
PMID:24365768 |
RGD:10402797 |
NCBI chrNW_004936647:2,510,457...2,518,576
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased activity:lung |
RGD |
PMID:18694576 |
RGD:5129703 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
treatment |
ISO |
|
RGD |
PMID:22503847 |
RGD:7240537 |
NCBI chrNW_004936470:20,480,844...20,485,955
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:20815765 PMID:25382268 |
RGD:11533932 RGD:4892012 |
NCBI chrNW_004936527:6,427,147...6,445,770
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:21781312 |
RGD:6771212 |
NCBI chrNW_004936475:19,771,384...19,785,034
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
protein:increased expression:alveolar macrophage (rat) |
RGD |
PMID:16449942 PMID:21781312 |
RGD:11541083 RGD:6771212 |
NCBI chrNW_004936541:4,873,459...4,919,787
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:19782612 |
RGD:11100035 |
NCBI chrNW_004936469:43,841,989...43,850,322
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
|
RGD |
PMID:11606484 |
RGD:11080966 |
NCBI chrNW_004936543:1,032,543...1,040,956
|
|
G |
Tlr4 |
toll like receptor 4 |
treatment |
ISO |
|
RGD |
PMID:22115333 |
RGD:10402095 |
NCBI chrNW_004936487:6,519,140...6,532,018
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
|
RGD |
PMID:17294835 |
RGD:4143397 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
|
ISO |
|
RGD |
PMID:18316485 |
RGD:2301903 |
NCBI chrNW_004936528:1,608,782...1,682,873
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16155579 |
|
NCBI chrNW_004936578:3,168,599...3,179,369
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10900253 PMID:17201736 |
RGD:5129149 |
NCBI chrNW_004936486:4,400,467...4,401,588
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
|
RGD |
PMID:16269402 |
RGD:1598746 |
NCBI chrNW_004936504:5,985,407...5,987,453
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
protein:increased expression:heart (rat) |
RGD |
PMID:16505177 |
RGD:1625342 |
NCBI chrNW_004936727:1,418,342...1,422,005
|
|
G |
Agl |
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
|
ISO |
|
RGD |
PMID:9281456 |
RGD:1598779 |
NCBI chrNW_004937224:23,225...32,639
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:2535056 PMID:19166939 |
|
NCBI chrNW_004936484:19,713,299...19,721,144
|
|
G |
Agtr1 |
angiotensin II receptor type 1 |
|
ISO |
protein:increased expression:myocardium |
RGD |
PMID:21078800 |
RGD:5129194 |
NCBI chrNW_004936519:6,831,096...6,873,977
|
|
G |
Aifm1 |
apoptosis inducing factor mitochondria associated 1 |
|
ISO |
protein:decreased expression:mitochondrion: |
RGD |
PMID:23685150 |
RGD:10053560 |
NCBI chrNW_004936479:1,441,508...1,477,133
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
protein:increased phosphorylation:heart left ventricle |
RGD |
PMID:20217242 |
RGD:5509104 |
NCBI chrNW_004936621:620,163...639,115
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
|
ISO |
|
RGD |
PMID:16418318 |
RGD:2313347 |
NCBI chrNW_004936661:2,652,568...2,694,039
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
|
RGD |
PMID:23468836 |
RGD:7241598 |
NCBI chrNW_004936558:4,362,693...4,387,705
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:20011686 |
RGD:2317527 |
NCBI chrNW_004936554:7,807,914...7,848,691
|
|
G |
Angpt2 |
angiopoietin 2 |
|
ISO |
mRNA, protein:increased expression:myocardium (rat) |
RGD |
PMID:12737621 |
RGD:1601505 |
NCBI chrNW_004936615:4,472,261...4,524,537
|
|
G |
Ank1 |
ankyrin 1 |
|
ISO |
|
RGD |
PMID:9378703 |
RGD:1599110 |
NCBI chrNW_004936785:738,323...944,734
|
|
G |
Ank2 |
ankyrin 2 |
|
ISO |
|
RGD |
PMID:9378703 |
RGD:1599110 |
NCBI chrNW_004936563:3,520,195...4,170,716
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
|
ISO |
protein:decreased expression:myocardium |
RGD |
PMID:19299913 |
RGD:5133278 |
NCBI chrNW_004936601:3,502,844...3,510,919
|
|
G |
Anxa1 |
annexin A1 |
treatment |
ISO |
protein:increased expression:heart, leukocyte |
RGD |
PMID:11641252 PMID:22924634 |
RGD:2306910 RGD:7421655 |
NCBI chrNW_004936503:9,124,314...9,142,372
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
ISO |
protein:altered localization:cytoplasm |
RGD |
PMID:17602955 |
RGD:2315672 |
NCBI chrNW_004936877:666,545...669,351
|
|
G |
Arrb2 |
arrestin beta 2 |
|
ISO |
|
RGD |
PMID:29016703 |
RGD:13506827 |
NCBI chrNW_004936677:3,173,054...3,181,475
|
|
G |
Atf3 |
activating transcription factor 3 |
|
ISO |
|
RGD |
PMID:11485922 |
RGD:7327201 |
NCBI chrNW_004936557:909,302...922,619
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29702141 |
|
NCBI chrNW_004936627:1,555,151...1,584,370
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
|
ISO |
|
RGD |
PMID:17630344 |
RGD:13782075 |
NCBI chrNW_004936501:11,818,301...11,836,221
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10734148 PMID:28637456 |
RGD:13782080 |
NCBI chrNW_004936558:3,300,941...3,357,595
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
treatment |
ISO |
protein:decreased expression:myocardium (rat) |
RGD |
PMID:25305180 PMID:26109848 |
RGD:13792666 RGD:13792676 |
NCBI chrNW_004936588:612,255...614,894
|
|
G |
Bad |
BCL2 associated agonist of cell death |
treatment |
ISO |
protein:increased expression, decreased serine phosphorylation:heart |
RGD |
PMID:15339931 PMID:23364609 |
RGD:10053674 RGD:2292700 |
NCBI chrNW_004936599:4,924,349...4,933,683
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20026869 PMID:21223820 PMID:25547710 |
RGD:10054103 RGD:13782178 |
NCBI chrNW_004936664:2,968,103...2,973,652
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:16289365 PMID:20821058 PMID:23364609 |
RGD:10053674 RGD:11561911 RGD:1599484 |
NCBI chrNW_004936497:2,209,136...2,373,580
|
|
G |
Bcl2l1 |
BCL2 like 1 |
treatment |
ISO |
|
RGD |
PMID:12668130 |
RGD:11035287 |
NCBI chrNW_004936485:18,654,046...18,707,324
|
|
G |
Becn1 |
beclin 1 |
treatment |
ISO |
|
RGD |
PMID:20812860 PMID:20821058 |
RGD:11561911 RGD:11561944 |
NCBI chrNW_004936490:17,518,100...17,531,126
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
ISO |
protein:increased cleavage:heart: |
RGD |
PMID:11934844 PMID:19940077 |
RGD:13782263 RGD:2317561 |
NCBI chrNW_004936807:708,340...750,127
|
|
G |
Blk |
BLK proto-oncogene, Src family tyrosine kinase |
|
ISO |
mRNA:increased expression:left ventricle (rat) |
RGD |
PMID:17562528 |
RGD:1642307 |
NCBI chrNW_004936675:3,228,982...3,246,617
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
treatment |
ISO |
|
RGD |
PMID:16645637 |
RGD:11561983 |
NCBI chrNW_004936486:18,449,371...18,460,435
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
|
ISO |
mRNA:increased expression:heart |
RGD |
PMID:12909328 |
RGD:2289075 |
NCBI chrNW_004936567:1,310,525...1,314,469
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased expression:myocardium |
RGD |
PMID:11560858 |
RGD:1582136 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:14998631 PMID:18470603 PMID:29538428 |
RGD:13782276 RGD:2293314 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Casp7 |
caspase 7 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:14998631 PMID:29538428 |
RGD:13782276 |
NCBI chrNW_004936486:4,082,664...4,114,942
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte |
CTD RGD |
PMID:11934844 PMID:14998631 |
RGD:13782263 |
NCBI chrNW_004936726:554,627...596,334
|
|
G |
Casp9 |
caspase 9 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte,endothelial cell |
RGD CTD |
PMID:11934844 PMID:14998631 PMID:29538428 |
RGD:13782263 RGD:13782276 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
Casr |
calcium sensing receptor |
|
ISO |
protein:increased expression:ventricular myocardium (rat) |
RGD |
PMID:21766206 |
RGD:7205698 |
NCBI chrNW_004936536:8,574,064...8,599,446
|
|
G |
Cast |
calpastatin |
|
ISO |
|
RGD |
PMID:12482022 |
RGD:5683872 |
NCBI chrNW_004936523:6,688,153...6,798,184
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:11510883 PMID:21600015 |
RGD:1581149 |
NCBI chrNW_004936533:3,601,270...3,637,128
|
|
G |
Cbl |
Cbl proto-oncogene |
severity |
ISO |
|
RGD |
PMID:24583314 |
RGD:11251947 |
NCBI chrNW_004936542:4,136,389...4,235,746
|
|
G |
Cflar |
CASP8 and FADD like apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:18466417 |
RGD:11341714 |
NCBI chrNW_004936726:381,888...425,565
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
|
RGD |
PMID:18771032 |
RGD:2316217 |
NCBI chrNW_004936510:3,779,930...3,806,615
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
|
ISO |
|
RGD |
PMID:17950273 |
RGD:2316224 |
NCBI chrNW_004936474:9,019,044...9,020,110
|
|
G |
Crp |
C-reactive protein |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21122204 |
RGD:5128547 |
NCBI chrNW_004936740:885,855...888,854
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
protein:decreased expression:blood, monocyte |
RGD |
PMID:15786508 |
RGD:4892017 |
NCBI chrNW_004936473:28,508,726...28,535,640
|
|
G |
Diablo |
diablo IAP-binding mitochondrial protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14998631 |
|
NCBI chrNW_004936558:2,260,459...2,268,941
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
|
ISO |
|
RGD |
PMID:12193087 PMID:18586023 |
RGD:4892580 RGD:7244160 |
NCBI chrNW_004936474:7,034,134...7,083,005
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15642760 PMID:16700825 PMID:18586023 |
RGD:4892580 |
NCBI chrNW_004936534:885,489...892,292
|
|
G |
Ednra |
endothelin receptor type A |
|
ISO |
|
RGD |
PMID:18586023 |
RGD:4892580 |
NCBI chrNW_004936535:1,950,117...2,005,786
|
|
G |
Ednrb |
endothelin receptor type B |
|
ISO |
|
RGD |
PMID:21048781 |
RGD:4892332 |
NCBI chrNW_004936511:3,446,864...3,478,434
|
|
G |
Egln1 |
egl-9 family hypoxia inducible factor 1 |
susceptibility |
ISO |
|
RGD |
PMID:20185832 |
RGD:11251775 |
NCBI chrNW_004936484:19,343,770...19,386,087
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19834332 |
|
NCBI chrNW_004936675:350,357...392,919
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
|
RGD |
PMID:18314151 |
RGD:4892299 |
NCBI chrNW_004936489:4,616,839...4,887,179
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
|
RGD |
PMID:18656630 |
RGD:5508820 |
NCBI chrNW_004936495:7,956,168...8,018,356
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
ISO |
|
RGD |
PMID:26038570 PMID:26948086 |
RGD:11341801 RGD:13792504 |
NCBI chrNW_004936599:633,501...639,412
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
|
RGD |
PMID:21316771 |
RGD:8686424 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
treatment |
ISO |
|
RGD |
PMID:27129213 |
RGD:11574725 |
NCBI chrNW_004936709:1,243,149...1,247,782
|
|
G |
Gcg |
glucagon |
treatment |
ISO |
|
RGD |
PMID:24125539 |
RGD:10402369 |
NCBI chrNW_004936469:16,906,658...16,916,045
|
|
G |
Glrx |
glutaredoxin |
|
ISO |
mRNA:decreased expression:heart: |
RGD |
PMID:18163565 |
RGD:2306160 |
NCBI chrNW_004936523:7,535,650...7,544,339
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
severity treatment susceptibility |
ISO |
protein:increased expression:heart, mitochondrion (mouse) associated with Diabetes Mellitus, Experimental associated with Hypertension |
RGD |
PMID:23467820 PMID:24170934 PMID:27296507 PMID:27601479 PMID:27865836 |
RGD:13513990 RGD:13513993 RGD:13513995 RGD:13792704 RGD:13792779 |
NCBI chrNW_004936599:2,437,061...2,456,141
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
ISO |
|
RGD |
PMID:20217242 PMID:26918336 PMID:29978610 |
RGD:13792725 RGD:13792772 RGD:5509104 |
NCBI chrNW_004936536:6,730,070...6,893,818
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
|
RGD |
PMID:24769323 |
RGD:10401892 |
NCBI chrNW_004936792:531,076...579,083
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:myocardium mRNA:increased expression:heart |
CTD RGD |
PMID:12189448 PMID:18549825 PMID:19727523 PMID:20170615 PMID:22050707 |
RGD:1626327 RGD:5147885 RGD:9068872 |
NCBI chrNW_004936495:5,770,988...5,816,157
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19540007 PMID:21113057 PMID:23531454 |
RGD:10402066 RGD:10402170 |
NCBI chrNW_004936472:25,236,728...25,246,585
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:12709584 PMID:22179023 PMID:23921302 |
RGD:10755573 RGD:10755585 RGD:1598392 |
NCBI chrNW_004936492:5,042,353...5,049,216
|
|
G |
Hrh2 |
histamine receptor H2 |
susceptibility |
ISO |
|
RGD |
PMID:23467745 |
RGD:9685524 |
NCBI chrNW_004936609:624,446...664,049
|
|
G |
Hrh3 |
histamine receptor H3 |
|
ISO |
|
RGD |
PMID:15076218 |
RGD:1626433 |
NCBI chrNW_004936514:9,862,104...9,865,614
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
|
ISO |
|
RGD |
PMID:22426029 |
RGD:10402789 |
NCBI chrNW_004936470:7,927,734...7,950,805
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
treatment |
ISO |
|
RGD |
PMID:24129401 PMID:25547710 |
RGD:11354962 RGD:13782178 |
NCBI chrNW_004936487:13,348,465...13,352,717
|
|
G |
Htra2 |
HtrA serine peptidase 2 |
|
ISO |
protein:increased expression:myocardium, cytosol (mouse) |
RGD |
PMID:15611365 |
RGD:5688376 |
NCBI chrNW_004936556:741,718...746,016
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:heart (rat) |
CTD RGD |
PMID:12087064 PMID:20851484 |
RGD:4145348 |
NCBI chrNW_004936659:616,570...627,172
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
protein:increased expression:plasma |
RGD |
PMID:19275881 PMID:23840272 |
RGD:2311056 RGD:7365001 |
NCBI chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il17a |
interleukin 17A |
treatment |
ISO |
|
RGD |
PMID:22030025 |
RGD:9068944 |
NCBI chrNW_004936476:8,621,860...8,625,008
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:19164288 PMID:19805173 |
RGD:4889400 RGD:4889578 |
NCBI chrNW_004936612:2,306,963...2,325,086
|
|
G |
Il18bp |
interleukin 18 binding protein |
|
ISO |
mRNA:increased expression:heart |
RGD |
PMID:19164288 PMID:19805173 |
RGD:4889400 RGD:4889578 |
NCBI chrNW_004936498:1,353,569...1,358,312
|
|
G |
Il18rap |
interleukin 18 receptor accessory protein |
|
ISO |
|
RGD |
PMID:19164288 |
RGD:4889578 |
NCBI chrNW_004936713:1,087,884...1,115,512
|
|
G |
Il1a |
interleukin 1 alpha |
treatment |
ISO |
|
RGD |
PMID:7622355 PMID:8576926 |
RGD:7794741 RGD:7794764 |
NCBI chrNW_004936783:1,210,715...1,218,315
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
mRNA:increased expression:heart |
RGD |
PMID:17134725 |
RGD:1626628 |
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
rat model treated with human protein |
RGD |
PMID:22649318 |
RGD:7174360 |
NCBI chrNW_004936783:1,447,158...1,466,331
|
|
G |
Il6r |
interleukin 6 receptor |
|
ISO |
|
RGD |
PMID:16056242 |
RGD:1625435 |
NCBI chrNW_004936580:4,055,438...4,081,876
|
|
G |
Irak1 |
interleukin 1 receptor associated kinase 1 |
|
ISO |
protein:increased activity:ventricle myocardium (rat) |
RGD |
PMID:15793310 |
RGD:1579809 |
NCBI chrNW_004936809:891,407...900,311
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:23747931 PMID:23796350 |
RGD:10403071 RGD:8694332 |
NCBI chrNW_004936503:111,722...243,627
|
|
G |
Kcnj11 |
potassium inwardly rectifying channel subfamily J member 11 |
|
ISO |
|
RGD |
PMID:17906066 |
RGD:7297046 |
NCBI chrNW_004936528:1,685,015...1,688,220
|
|
G |
Kcnj8 |
potassium inwardly rectifying channel subfamily J member 8 |
|
ISO |
|
RGD |
PMID:12234964 |
RGD:729109 |
NCBI chrNW_004936548:5,125,583...5,132,490
|
|
G |
Kng1 |
kininogen 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:2535056 PMID:7856280 |
|
NCBI chrNW_004936578:3,255,335...3,281,296
|
|
G |
Lep |
leptin |
|
ISO |
|
RGD |
PMID:21122204 |
RGD:5128547 |
NCBI chrNW_004936479:15,394,966...15,411,334
|
|
G |
Lepr |
leptin receptor |
|
ISO |
mRNA:altered expression:heart: mRNA:decreased expression:heart |
RGD |
PMID:15284063 PMID:17134725 |
RGD:1626628 RGD:5129123 |
NCBI chrNW_004936591:5,771,371...5,846,177
|
|
G |
LOC101959685 |
complement C5 |
treatment |
ISO |
|
RGD |
PMID:9631876 PMID:23067403 |
RGD:1600666 RGD:7411626 |
NCBI chrNW_004936487:9,391,774...9,474,168
|
|
G |
LOC101966907 |
histone H2AX |
treatment |
ISO |
|
RGD |
PMID:23108649 |
RGD:8693739 |
NCBI chrNW_004936542:4,046,930...4,049,017
|
|
G |
LOC101966992 |
cytochrome b-245 heavy chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19207477 |
|
NCBI chrNW_004936502:4,631,750...4,676,686
|
|
G |
Lum |
lumican |
|
ISO |
|
RGD |
PMID:11348051 |
RGD:1582122 |
NCBI chrNW_004936507:7,847,761...7,855,311
|
|
G |
Map1lc3a |
microtubule associated protein 1 light chain 3 alpha |
treatment |
ISO |
protein:increased expression:heart |
RGD |
PMID:20812860 PMID:20821058 |
RGD:11561911 RGD:11561944 |
NCBI chrNW_004936561:6,104,748...6,106,348
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
treatment |
ISO |
|
RGD |
PMID:15653762 PMID:25345742 |
RGD:13800900 RGD:1582282 |
NCBI chrNW_004936619:1,889,841...1,932,646
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
|
ISO |
|
RGD |
PMID:14749328 |
RGD:7495840 |
NCBI chrNW_004936476:23,237,762...23,310,211
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
treatment |
ISO |
|
RGD |
PMID:25345742 PMID:28814571 PMID:29741915 |
RGD:13800564 RGD:13800874 RGD:13800900 |
NCBI chrNW_004936501:12,342,670...12,390,650
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
|
RGD |
PMID:12883833 PMID:15309413 |
RGD:1582311 RGD:1582312 |
NCBI chrNW_004936728:1,775,746...1,893,895
|
|
G |
Mb |
myoglobin |
|
ISO |
|
RGD |
PMID:11972171 PMID:15132981 |
RGD:1582385 RGD:1582431 |
NCBI chrNW_004936492:4,890,871...4,897,665
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
|
ISO |
protein:increased serine phosphorylation:heart ventricle (rat) |
RGD |
PMID:14644432 |
RGD:2317401 |
NCBI chrNW_004936545:6,709,903...6,732,334
|
|
G |
Mfn2 |
mitofusin 2 |
treatment |
ISO |
|
RGD |
PMID:24721408 |
RGD:13204835 |
NCBI chrNW_004936474:767,754...795,258
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
|
ISO |
|
RGD |
PMID:22405128 |
RGD:6483543 |
NCBI chrNW_004936486:15,561,327...15,587,109
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
|
ISO |
|
RGD |
PMID:12892382 PMID:17996137 |
RGD:1582539 RGD:7207397 |
NCBI chrNW_004936551:5,167,909...5,175,149
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
treatment |
ISO |
|
RGD |
PMID:16699069 PMID:23889688 |
RGD:1582614 RGD:8657084 |
NCBI chrNW_004936475:7,801,356...7,825,831
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
|
ISO |
|
RGD |
PMID:14962484 |
RGD:1302746 |
NCBI chrNW_004936473:27,672,237...27,676,339
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
treatment |
ISO |
|
RGD |
PMID:21700931 |
RGD:13801200 |
NCBI chrNW_004936631:2,503,353...2,538,957
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2 like 2 |
|
ISO |
|
RGD |
PMID:24915518 |
RGD:10412738 |
NCBI chrNW_004936509:6,589,967...6,621,171
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
treatment |
ISO |
|
RGD |
PMID:19304943 |
RGD:10413871 |
NCBI chrNW_004936494:9,537,793...9,541,187
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:decreased expression:heart (rat) |
CTD RGD |
PMID:12003803 PMID:12087064 PMID:14990356 PMID:19207477 PMID:20828608 PMID:21844074 |
RGD:5509098 |
NCBI chrNW_004936538:4,052,277...4,097,051
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:12354446 PMID:18390819 PMID:20828747 PMID:29274587 PMID:29299201 |
RGD:13503347 RGD:13504684 RGD:2292091 RGD:4891991 |
NCBI chrNW_004936527:6,427,147...6,445,770
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
|
RGD |
PMID:21168723 |
RGD:5685663 |
NCBI chrNW_004936474:683,325...684,662
|
|
G |
Nppc |
natriuretic peptide C |
|
ISO |
|
RGD |
PMID:15337698 |
RGD:1580149 |
NCBI chrNW_004936525:5,092,675...5,099,344
|
|
G |
Npr3 |
natriuretic peptide receptor 3 |
|
ISO |
|
RGD |
PMID:15337698 |
RGD:1580149 |
NCBI chrNW_004936518:8,093,111...8,158,862
|
|
G |
Npy1r |
neuropeptide Y receptor Y1 |
|
ISO |
mRNA:decreased expression:heart left ventricle |
RGD |
PMID:17562528 |
RGD:1642307 |
NCBI chrNW_004936555:2,267,727...2,276,673
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
treatment |
ISO |
|
RGD |
PMID:12384456 |
RGD:628368 |
NCBI chrNW_004936902:405,536...416,393
|
|
G |
Oprd1 |
opioid receptor delta 1 |
|
ISO |
|
RGD |
PMID:12136724 |
RGD:2316590 |
NCBI chrNW_004936474:12,860,293...12,902,389
|
|
G |
P2ry12 |
purinergic receptor P2Y12 |
|
ISO |
|
RGD |
PMID:20431845 |
RGD:6480645 |
NCBI chrNW_004936758:1,581,828...1,624,332
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
|
ISO |
|
RGD |
PMID:9670921 PMID:23598272 |
RGD:11073735 RGD:5683917 |
NCBI chrNW_004936526:3,102,468...3,147,601
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
treatment |
ISO |
|
RGD |
PMID:18055876 |
RGD:9835369 |
NCBI chrNW_004936698:650,225...746,593
|
|
G |
Pdia3 |
protein disulfide isomerase family A member 3 |
|
ISO |
|
RGD |
PMID:12872233 |
RGD:1624250 |
NCBI chrNW_004936471:6,809,181...6,834,189
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:8989147 |
RGD:2311662 |
NCBI chrNW_004936541:4,873,459...4,919,787
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
|
ISO |
|
RGD |
PMID:20179753 |
RGD:6482687 |
NCBI chrNW_004936479:17,084,006...17,112,264
|
|
G |
Plcd1 |
phospholipase C delta 1 |
|
ISO |
protein:altered activity |
RGD |
PMID:12623065 |
RGD:1304368 |
NCBI chrNW_004936473:27,364,404...27,387,337
|
|
G |
Pld2 |
phospholipase D2 |
|
ISO |
protein:altered activity:sarcolemma, sarcoplasmic reticulum, heart left ventricle |
RGD |
PMID:15752718 |
RGD:2299906 |
NCBI chrNW_004936677:2,870,664...2,883,545
|
|
G |
Pln |
phospholamban |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10734148 PMID:21934351 |
RGD:7327186 |
NCBI chrNW_004936658:1,443,626...1,453,770
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16411023 |
|
NCBI chrNW_004936629:3,672,445...3,725,645
|
|
G |
Ppard |
peroxisome proliferator activated receptor delta |
|
ISO |
|
RGD |
PMID:19997057 |
RGD:2324876 |
NCBI chrNW_004936476:23,799,285...23,886,606
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
|
RGD |
PMID:18562925 |
RGD:2301853 |
NCBI chrNW_004936602:1,230,907...1,368,588
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
treatment |
ISO |
|
RGD |
PMID:19096023 |
RGD:10059669 |
NCBI chrNW_004936477:4,881,230...5,488,208
|
|
G |
Prkcb |
protein kinase C beta |
|
ISO |
|
RGD |
PMID:15878997 |
RGD:1625520 |
NCBI chrNW_004936501:8,410,273...8,729,238
|
|
G |
Prkcd |
protein kinase C delta |
|
ISO |
protein:decreased expression:heart |
RGD |
PMID:17322024 |
RGD:1642542 |
NCBI chrNW_004936473:3,892,625...3,923,467
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
treatment |
ISO |
|
RGD |
PMID:18332860 PMID:19845676 |
RGD:7777120 RGD:7777130 |
NCBI chrNW_004936787:330,390...1,491,994
|
|
G |
Procr |
protein C receptor |
treatment |
ISO |
|
RGD |
PMID:26994471 |
RGD:13515126 |
NCBI chrNW_004936561:5,557,640...5,562,981
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19038262 |
|
NCBI chrNW_004936735:1,252,414...1,338,318
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
treatment |
ISO |
|
RGD |
PMID:10193764 |
RGD:10043342 |
NCBI chrNW_004936591:1,174,364...1,250,233
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:17660401 |
RGD:2300261 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Rap1a |
RAP1A, member of RAS oncogene family |
treatment |
ISO |
|
RGD |
PMID:20501665 |
RGD:10003160 |
NCBI chrNW_004936690:275,840...363,752
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
protein:altered localization:nucleus |
RGD |
PMID:18636044 |
RGD:2298773 |
NCBI chrNW_004936599:3,800,142...3,810,583
|
|
G |
Rhoa |
ras homolog family member A |
|
ISO |
protein:altered localization:heart |
RGD |
PMID:17322412 |
RGD:1642967 |
NCBI chrNW_004936529:1,000,050...1,045,655
|
|
G |
Rnls |
renalase, FAD dependent amine oxidase |
|
ISO |
|
RGD |
PMID:21178975 |
RGD:7327174 |
NCBI chrNW_004936735:659,826...1,048,135
|
|
G |
Selp |
selectin P |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12087064 PMID:21146547 |
RGD:6480105 |
NCBI chrNW_004936481:17,076,660...17,112,501
|
|
G |
Serpina3 |
serpin family A member 3 |
|
ISO |
|
RGD |
PMID:7562495 |
RGD:5147423 |
NCBI chrNW_004936846:174,411...182,053
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
|
RGD |
PMID:26958805 |
RGD:11073621 |
NCBI chrNW_004936543:1,032,543...1,040,956
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:16942749 |
RGD:8661647 |
NCBI chrNW_004936581:4,911,403...4,924,484
|
|
G |
Sfrp2 |
secreted frizzled related protein 2 |
|
ISO |
|
RGD |
PMID:19109969 |
RGD:4107088 |
NCBI chrNW_004936576:604,174...612,440
|
|
G |
Sh2b3 |
SH2B adaptor protein 3 |
|
ISO |
|
RGD |
PMID:25628389 |
RGD:12904914 |
NCBI chrNW_004936558:4,103,898...4,126,883
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
ISO |
protein:increased expression:heart |
RGD |
PMID:18228117 |
RGD:2306299 |
NCBI chrNW_004936527:10,033,095...10,042,713
|
|
G |
Sirt1 |
sirtuin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21060073 |
|
NCBI chrNW_004936521:10,296,097...10,316,673
|
|
G |
Slc25a4 |
solute carrier family 25 member 4 |
treatment |
ISO |
|
RGD |
PMID:24126566 |
RGD:9681554 |
NCBI chrNW_004936554:4,130,461...4,135,046
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
|
ISO |
|
RGD |
PMID:10336852 |
RGD:12879857 |
NCBI chrNW_004936474:24,205,878...24,236,611
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
|
ISO |
|
RGD |
PMID:10336852 |
RGD:12879857 |
NCBI chrNW_004936595:567,267...574,051
|
|
G |
Slc8a1 |
solute carrier family 8 member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiac muscle cell |
CTD RGD |
PMID:15215644 PMID:17267548 PMID:17822695 |
RGD:1642716 RGD:1642729 |
NCBI chrNW_004936508:10,894,918...11,256,084
|
|
G |
Slc9a1 |
solute carrier family 9 member A1 |
|
ISO |
|
RGD |
PMID:22803959 |
RGD:6771238 |
NCBI chrNW_004936474:11,460,266...11,517,420
|
|
G |
Smad1 |
SMAD family member 1 |
|
ISO |
|
RGD |
PMID:15911698 |
RGD:1643233 |
NCBI chrNW_004936535:3,582,512...3,626,312
|
|
G |
Smad3 |
SMAD family member 3 |
treatment |
ISO |
|
RGD |
PMID:22913380 |
RGD:12903950 |
NCBI chrNW_004936471:27,080,662...27,185,861
|
|
G |
Smad4 |
SMAD family member 4 |
treatment |
ISO |
|
RGD |
PMID:22913380 |
RGD:12903950 |
NCBI chrNW_004936497:12,242,869...12,278,012
|
|
G |
Sod1 |
superoxide dismutase 1 |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:12668130 PMID:19277497 PMID:23629152 |
RGD:11035287 RGD:8655884 RGD:8655965 |
NCBI chrNW_004936500:10,345,154...10,352,873
|
|
G |
Sod2 |
superoxide dismutase 2 |
treatment |
ISO |
|
RGD |
PMID:11864929 PMID:12668130 |
RGD:11035287 RGD:1581222 |
NCBI chrNW_004936489:11,178,338...11,191,601
|
|
G |
Sord |
sorbitol dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased activity:heart |
CTD RGD |
PMID:14525943 PMID:18549825 |
RGD:1601364 |
NCBI chrNW_004936471:7,760,097...7,805,475
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
|
RGD |
PMID:15165989 |
RGD:1581342 |
NCBI chrNW_004936905:148,956...156,023
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
ISO |
protein:increased phosphorylation:heart |
RGD |
PMID:16935931 |
RGD:1600091 |
NCBI chrNW_004936506:7,196,860...7,235,854
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
treatment |
ISO |
|
RGD |
PMID:23796350 |
RGD:8694332 |
NCBI chrNW_004936490:17,119,189...17,178,402
|
|
G |
Suv39h1 |
suppressor of variegation 3-9 homolog 1 |
treatment |
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:24752040 |
RGD:9586740 |
NCBI chrNW_004936721:646,778...661,144
|
|
G |
Tek |
TEK receptor tyrosine kinase |
|
ISO |
mRNA, protein:increased expression:ventricle myocardium |
RGD |
PMID:12737621 |
RGD:1601505 |
NCBI chrNW_004936611:2,420,176...2,531,726
|
|
G |
Tfrc |
transferrin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18549825 |
|
NCBI chrNW_004936784:696,738...728,385
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
treatment |
ISO |
|
RGD |
PMID:22913380 |
RGD:12903950 |
NCBI chrNW_004936661:3,742,080...3,758,266
|
|
G |
Thbs1 |
thrombospondin 1 |
|
ISO |
mRNA:increased expression:heart |
RGD |
PMID:16179730 |
RGD:2317960 |
NCBI chrNW_004936471:3,064,466...3,081,125
|
|
G |
Timp4 |
TIMP metallopeptidase inhibitor 4 |
|
ISO |
protein:increased expression:blood |
RGD |
PMID:12707244 |
RGD:2290461 |
NCBI chrNW_004936602:1,488,993...1,496,108
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:19274437 |
RGD:2312688 |
NCBI chrNW_004936576:522,234...531,660
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
|
RGD |
PMID:14962484 |
RGD:1302746 |
NCBI chrNW_004936487:6,519,140...6,532,018
|
|
G |
Tnc |
tenascin C |
|
ISO |
|
RGD |
PMID:20554738 |
RGD:4889599 |
NCBI chrNW_004936487:4,172,263...4,256,780
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum, heart: |
RGD |
PMID:24157164 |
RGD:7387274 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
protein:increased expression:heart |
RGD |
PMID:18317410 |
RGD:2290554 |
NCBI chrNW_004936595:919,807...935,367
|
|
G |
Txn |
thioredoxin |
|
ISO |
mRNA:decreased expression:heart |
RGD |
PMID:18045550 |
RGD:2306159 |
NCBI chrNW_004936559:2,811,786...2,822,528
|
|
G |
Txn2 |
thioredoxin 2 |
|
ISO |
mRNA, protein:decreased expression:heart |
RGD |
PMID:18045550 |
RGD:2306159 |
NCBI chrNW_004936492:4,310,394...4,320,714
|
|
G |
Ucn |
urocortin |
|
ISO |
|
RGD |
PMID:15806110 |
RGD:1642783 |
NCBI chrNW_004936493:5,258,574...5,260,692
|
|
G |
Ucp2 |
uncoupling protein 2 |
|
ISO |
mRNA:increased expression:myocardium |
RGD |
PMID:19526854 |
RGD:2313528 |
NCBI chrNW_004936498:3,059,700...3,066,112
|
|
G |
Ucp3 |
uncoupling protein 3 |
|
ISO |
mRNA:increased expression:myocardium |
RGD |
PMID:19526854 |
RGD:2313528 |
NCBI chrNW_004936498:3,082,575...3,095,739
|
|
G |
Uts2 |
urotensin 2 |
|
ISO |
|
RGD |
PMID:17900760 |
RGD:2306836 |
NCBI chrNW_004936623:2,339,259...2,345,717
|
|
G |
Uts2r |
urotensin 2 receptor |
|
ISO |
|
RGD |
PMID:17900760 |
RGD:2306836 |
NCBI chrNW_004936923:24,952...31,083
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
protein:increased expression:heart |
RGD |
PMID:23052973 |
RGD:7207792 |
NCBI chrNW_004936748:785,491...802,791
|
|
G |
Vcan |
versican |
|
ISO |
mRNA:increased expression:heart |
RGD |
PMID:16311904 |
RGD:1598497 |
NCBI chrNW_004936469:2,585,142...2,688,029
|
|
G |
Vdac1 |
voltage dependent anion channel 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25488258 |
|
NCBI chrNW_004936647:1,220,075...1,249,579
|
|
G |
Vdr |
vitamin D receptor |
|
ISO |
mRNA,protein:increased expression, activity:heart: |
RGD |
PMID:25365634 |
RGD:13432076 |
NCBI chrNW_004936512:5,741,836...5,800,999
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22050707 |
|
NCBI chrNW_004936476:16,245,134...16,261,180
|
|
G |